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Summary
Biogenesis of eukaryotic mRNAs involves pre-mRNA synthesis by RNA polymerase (Pol) II and co-
transcriptional RNA processing, which encompasses 5’-capping, intron splicing, and 3’-RNA cleavage
and polyadenylation (3’-processing). The mature mRNA is packaged with RNA-binding proteins (RBPs)
into messenger ribonucleoprotein particles (mRNPs) and exported to the cytoplasm where it directs pro-
tein synthesis. Factors for mRNP biogenesis are recruited co-transcriptionally by interactions with the
C-terminal domain (CTD) of Pol II (Buratowski, 2009; Heidemann and Eick, 2012; Hsin and Manley,
2012) and by interactions with the emerging pre-mRNA transcript (Mandel et al., 2008; Wahl et al., 2009;
Chan et al., 2011; Proudfoot, 2011; Darnell, 2013; Mller-McNicoll and Neugebauer, 2013).
Mapping of mRNP biogenesis factors onto pre-mRNA and mature mRNA promises insights into RNA
determinants for splicing, 3’-processing, and RNA export, and the coupling between these processes.
Biogenesis factors can in principle be mapped onto the transcriptome by in vivo protein-RNA cross-linking
and immunoprecipitation (CLIP) (Ule et al., 2003). CLIP is based on UV light-induced cross-linking and
identifies direct protein-RNA interaction sites after sequencing of the cross-linked RNA regions (Milek
et al., 2012). CLIP-based methods could indeed provide transcriptome maps for several human 3’-
processing factors (Martin et al., 2012) and mRNA-binding proteins in the yeast Saccharomyces cere-
visiae (Tuck and Tollervey, 2013). However, mRNP biogenesis factors have not been systematically
mapped onto pre-mRNA, likely due to difficulties in trapping short-lived RNAs in cells, and due to the
complexity caused by the large variety of pre-mRNA species.
Here I mapped 23 mRNP biogenesis factors onto the newly synthesized yeast transcriptome, providing
105–106 high-confidence RNA interaction sites per factor. These maps were obtained by photoactivat-
able-ribonucleoside-enhanced (PAR)-CLIP, which was developed in human cells (Hafner et al., 2010)
and recently adopted to yeast (Creamer et al., 2011; Schulz et al., 2013). For data analysis, I helped to
develop a computational pipeline based on advanced statistical models and motif searches with XXmotif
(Hartmann et al., 2013). The programming and modulation of the pipeline was performed by Phillipp
Torkler. I show that PAR-CLIP efficiently captures short-lived pre-mRNA intermediates, and provide deep
insights into the in vivo RNA-binding preferences of mRNA biogenesis factors. My analysis includes
factors implicated in 5’-cap binding, splicing, 3’-processing, and mRNA export. They define conserved
interactions between the splicing factors Mud2-Msl5 (U2AF65-BBP) and U1/U2 snRNPs, and pre-mRNA
introns. They also identify a unified arrangement of the 3’-processing factors CPF/CPSF and CFIA/CstF
at pre-mRNA polyadenylation (pA) sites in yeast and humans, which results from a distinct A/U dinu-
cleotide signature. Furthermore, global analysis of the data indicates that 3’-processing factors have
roles in RNA splicing and surveillance, and couple biogenesis events to restrict nuclear export to mature
mRNPs.
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1 Introduction
1.1 Not only DNA’s messenger
Every known form of life on Earth is based on three major macromolecules: deoxyribonucleic acid
(DNA), ribonucleic acid (RNA), and proteins. Francis Crick’s ’central dogma of molecular biology’, put
simply, describes it as follows: ”DNA makes RNA, RNA makes proteins, proteins make us” (Crick,
1958). While DNA functions as repository of the cellular information, the genetic code, RNA was long
believed to be only DNA’s messenger, a simple intermediate between DNA and protein synthesis,
obtained from gene transcription. Generally, a nascent RNA is synthesized from a DNA template by a
DNA-dependent RNA polymerase (Pol). In bacteria and archaea, all forms of RNA are transcribed by
one single polymerase (Zhang et al., 1999). In an eukaryotic cell, RNA transcription is carried out by
four polymerases: Pol I, Pol II, Pol III and the mitochondrial RNA polymerase (mitoPol) (Vannini and
Cramer, 2012; Schwinghammer et al., 2013). While Pol II transcribes messenger RNA (mRNA) and
several small RNAs, polymerase I and III produce ribosomal RNA (rRNA) and transfer RNA (tRNA), re-
spectively (Vannini and Cramer, 2012). Further Pol II-synthesized transcripts are small nuclear RNAs
(snRNAs), small nucleolar RNAs (snoRNAs), stable unannotated transcripts (SUTs), cryptic unstable
transcripts (CUTs), and non-coding RNAs (Vannini and Cramer, 2012; Schulz et al., 2013).
However, from an evolutionary point of view, RNA is supposed to be the older, primordial molecule
that preceded the contemporary DNA- and protein-based life (Woese et al., 1966; Crick, 1968). Espe-
cially the discovery of the ability of RNA to catalyze and theoretically replicate itself by forming complex
secondary structures (Kruger et al., 1982; Guerrier-Takada et al., 1983; Cech, 1986), inflamed the so
called ’RNA world’ hypothesis, and therefore resulted in a variety of models proposing the possible
existence of ancient ”Ribo-organism” that carried out complex, RNA-based metabolism even before
higher molecules evolutionarily appeared (Cech, 1986; Gilbert, 1987; Benner et al., 1989).
Due to the capacity of being both genetic material and cellular enzyme (referred to as ribozyme)
(Kruger et al., 1982; Guerrier-Takada et al., 1983), RNA was now considered an underestimated,
multitalented molecule with still unknown functions. The discovery that modern organisms like Gram-
positive bacteria and plants are capable to selectively bind metabolites by using so called riboswitches,
additionally supported the hypothesis that ancient regulatory and sensory systems might have been
initially based on exclusively RNA molecules (Ellington and Szostak, 1990; Winkler et al., 2002; Man-
dal and Breaker, 2004; Cochrane and Strobel, 2008; Roth and Breaker, 2009).
Despite the ability of RNA molecules to accomplish sophisticated reactions, especially in large RNA
complexes (Ferr-D’Amar and Scott, 2010), modern RNAs commonly operate in concert with RNA-
binding proteins (RBPs) and several protein complexes (Spliceosome, Ribosome, etc.), which mainly
benefit from direct RNA–RNA interactions as well as the catalytic activity of involved RNAs (Will and
Lhrmann, 2011; Moore and Steitz, 2011).
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1.2 The complex networks of mRNA’s life
The biogenesis of mRNAs in S. cerevisiae involves pre-mRNA synthesis by RNA Pol II and co-
transcriptional RNA processing, which encompasses 5’-capping, intron splicing, and 3’-end RNA cleav-
age and polyadenylation (3’ processing). The mature mRNA is packaged with RBPs into messenger
ribonucleoprotein particles (mRNPs) and exported to the cytoplasm, where it directs protein synthe-
sis. Factors for mRNP biogenesis are recruited co-transcriptionally by interactions with the C-terminal
domain (CTD) of the largest subunit of Pol II (Rpb1) (Buratowski, 2009; Heidemann and Eick, 2012;
Hsin and Manley, 2012) and by interactions with the emerging pre-mRNA transcript (Mandel et al.,
2008; Wahl et al., 2009; Proudfoot, 2011; Darnell, 2013; Mller-McNicoll and Neugebauer, 2013).
Release
Export
RNA abundance
Figure 1.1: The complex networks of mRNA’s life [adapted from Danckwardt et al. (2008)]. All main steps during
transcription (grey arrow) are functionally interconnected to mRNA processing (yellow center) and post-
transcriptional mechanisms (blue arrow).
1.2.1 The CTD code controls mRNA fate
The CTD is a unique domain composed of heptapeptide repeats with the consensus sequence Tyr1-
Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 (Y1S2P3T4S5P6S7) that is conserved from yeast to humans (Bura-
towski, 2009; Heidemann and Eick, 2012; Hsin and Manley, 2012). The number of repeats depends
on the complexity of the organism ranging from 27 repeats in S. cerevisiae to 52 in Homo sapiens
(Chapman et al., 2008). In yeast, more than seven repeats are required for cell viability (West and
Corden, 1995).
16
1 Introduction
Table 1.1: Relevant kinases (”writers”) and phosphatases (”eraser”) for in vivo CTD modification. The capital
letter ’P’ marks the phoshorylation state of the peptide. Neither a kinase nor phosphatase is known for
Thr4, which was consequently excluded from this list.
Peptide Kinase(s) Phosphatase(s) Citations
Tyr1 - Glc7 Schreieck et al. (2014)
Ser2 Bur1, Ctk1 Fcp1 Archambault et al. (1997); Patturajan et al. (1999)
Murray et al. (2001)
Ser5 Kin28 Rtr1, Ssu72 Mosley et al. (2009); Akhtar et al. (2009); Xiang et al. (2012)
Ser7 Kin28 Ssu72 Akhtar et al. (2009); Xiang et al. (2012)
Five out of seven residues can be phosphorylated and dephosphorylated by kinases (”writers”) and
phosphatases (”eraser”), respectively (Table 1.1) (Kim et al., 2009; Mayer et al., 2010). Importantly,
each repeat can be treated separately, resulting in a unique code with 128 theoretical combinations
per repeat (27) or a total of about 7.85×1056 different combinations over the entire yeast CTD (Hei-
demann and Eick, 2012; Schreieck et al., 2014).
Due to its unique and changeable code (Figure 1.2), the Pol II CTD primarily functions as a gen-
eral recruiting platform for several proteins (”CTD readers”) that are involved in transcription initiation,
elongation and termination, as well as in co-transcriptional RNA processing, export and histone mod-
ification (Maxon et al., 1994; Cho et al., 1997; Schroeder et al., 2000; Ng et al., 2003; Buratowski,
2009; Mayer et al., 2010; Kubicek et al., 2012; Meinel et al., 2013).
Figure 1.2: Coordination of the Pol II transcription cycle by the CTD code [adapted from Heidemann et al.
(2013)]. Main stages of the Pol II transcription cycle are centered and indicated by the black circle,
including the transcription start site (TSS) as well as the cleavage and polyadenylation site (pA). The
surrounding arcs symbolize the five modifiable peptides of a CTD repeat in a specific color code. The
stronger the color saturation, the stronger is the expected phosphorylation level of the peptide at this
state during the transcription cycle.
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1.2.2 Initiation of transcription and subsequent 5’-capping
The earliest steps in transcription initiation are the assembly of the pre-initiation complex (PIC) and
the recruitment of RNA Pol II to the gene promoter, accompanied by large complexes such as nucle-
osome remodelers (SWI/SNF) or histone modifiers (INO80/SWR1) (Wilson et al., 1996; Buratowski,
2009; Tosi et al., 2013). Briefly, the TATA box is bound by the TATA-binding protein (TBP), a sub-
unit of the transcription factor II (TFII)D, followed by the recruitment of TFIIA and TFIIB (Buratowski
et al., 1989; Thomas and Chiang, 2006). Subsequently, the Mediator complex, which functions as co-
activator and connector, delivers Pol II to the emerging PIC, assisted by its direct interaction with the
hypophosphorylated CTD (Myers et al., 1998; Bourbon et al., 2004; Kornberg, 2005). The transcription
factors IIE and IIF then bind preferentially to Pol II and its CTD, and finally recruit TFIIH (Maxon et al.,
1994; Kang and Dahmus, 1995). This last transcription factor functions in two ways: (i) it unwinds the
DNA and thus assists in the formation of an open complex (Giardina and Lis, 1993; Kostrewa et al.,
2009; Grnberg et al., 2012), and (ii) it phosphorylates the Ser5 and Ser7 residues of the CTD by its
kinase subunit Kin28 (Table 1.1 and Figure 1.2) (Akhtar et al., 2009). This specific mark leads to the
dissociation of the Mediator complex and allows Pol II to start scanning for the initiator element or
transcription start site (TSS) (40–120 bp downstream of the TATA box) (Sgaard and Svejstrup, 2007).
This process is referred to as promoter clearance or promoter escape (Luse, 2013).
After reaching the TSS, Pol II starts transcribing the first 12 to 13 nucleotides (nt) until the nascent
RNA fragment clashes with TFIIB, which is subsequently released, and therefore triggers the for-
mation of a stable transcription elongation complex (TEC) (Hahn, 2004; Sainsbury et al., 2013). To
protect the growing, nascent transcript from degradation, it is being capped within three catalytic re-
actions (Ghosh and Lima, 2010). Firstly, the γ-phosphate from the 5’-triphosphate is removed by the
5’-triphosphatase Cet1. Secondly, the guanylyltransferase Ceg1 adds an inverted guanylyl group. Fi-
nally, the methyltransferase Abd1 adds a methyl group to the N7 atom of the terminal guanine group.
Both Ceg1 and Abd1 are previously recruited by the phosphorylated CTD (Figure 1.3) (Cho et al.,
1997; Schroeder et al., 2000). Futhermore, Abd1 is hypothesized to have influence on promoter es-
cape in a methyltransferase-independent manner (Schroeder et al., 2004).
To ensure that only correctly capped transcripts pursue the productive elongation phase, nascent
transcripts might be qualitatively controlled during the promoter-proximal pausing (Kim et al., 2004a;
Mandal et al., 2004; Jiao et al., 2010). Whereas transcripts without or with aberrant cap structures are
co-transcriptionally removed by the Rai1-Rat1 decay pathway (Buratowski, 2009; Xiang et al., 2009;
Jiao et al., 2010), completed 7-methyl-guanosine (m7G) caps are associate with the cap-binding com-
plex (CBC) that functions in both pre-mRNA splicing and mRNA export (Schwer and Shuman, 1996;
Lewis and Izaurralde, 1997; Calero et al., 2002; Mazza et al., 2002). Abd1 and CBC are important for
recruitment of the kinases Ctk1 and Bur1 (Table 1.1), which promote elongation and capping enzyme
release (Lidschreiber et al., 2013).
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However, once the TEC is formed and the 5’-capping checkpoint has been overcome, the initiation-
elongation transition takes place, meaning the exchange of initiation factors by elongation factors
like Spt4/5/6, which finally introduces the productive elongation phase (Mayer et al., 2010; Martinez-
Rucobo et al., 2011; Lidschreiber et al., 2013).
A B
7-methylguanosine
5’-5’ triphosphate bridge
CTD repeat
TSS ~110 nt downstream of TSS
Figure 1.3: Recruitment and regulation of the capping enzymes. A. The guanylyltransferase Ceg1 binds phos-
phorylated Ser5 (green) and recruits the triphosphatase Cet1 by direct binding. ChIP experiments
showed that Spt5 contributes to stable recruitment of the mRNA capping enzymes Cet1, Ceg1, and
Abd1 (Lidschreiber et al., 2013) [adapted from Jeronimo et al. (2013)]. B. Completed 7-methylguanosine
(m7G) cap structure, connected to the 5’-end of mRNA via a 5’-to-5’-triphosphate bridge.
1.2.3 Elongation factors ensure barrier-free transcription
Efficient transcript elongation must overcome several blocks that are intrinsic to Pol II and its chro-
matinized DNA template. Because the chromatin architecture represents a barrier to the transcribing
elongation complex, histone structures have to be displayed. One essential complex that stimulates
both transcription elongation and Pol II productivity is the Spt4/5 or yeast DSIF complex (Hartzog and
Fu, 2013). After binding to the Pol II clamp domain, Spt5 recruits and binds Spt4 (Hartzog et al.,
1998; Martinez-Rucobo et al., 2011; Hartzog and Fu, 2013). This complex formation is a kind of an
”initial spark” that enables further reactions. For instance, Spt4/5 directly interacts with the elonga-
tion factor Spt6, which reassembles chromatin after Pol II has passed (Figure 1.4) (Hartzog et al.,
1998). Furthermore, Spt5 possesses a repetitive C-terminal region (CTR) (Swanson et al., 1991;
Zhou et al., 2009). Similar to the CTD, this region functions as platform to recruit further proteins
(Zhou et al., 2009). One complex that needs to be recruited by the CTR, is the Pol II-associated fac-
tor (PAF) complex (Zhou et al., 2009; Liu et al., 2009). Like Spt4/5, PAF is required to recruit histone
H3K4 methyltransferase Set1 and Spt16, members of the COMPASS and FACT complex, respectively
(Belotserkovskaya et al., 2003; Krogan et al., 2003; Kim et al., 2004b). Set1 in particular also in-
teracts with phosphorylated Ser5 and enables proper H3K4 methylation (H3K4me) to finally ensure
further histone acetylation and a barrier-free passing of the TEC (Smolle and Workman, 2013). The
Set1-dependent H3K4me additionally recruits Nrd1, allowing early termination by the Nrd1-Nab3-Sen1
pathway (Figure 1.4) (Terzi et al., 2011).
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H2A-H2B
H3-H4
Set1
COMPASS
H3K4me
Nrd1
Figure 1.4: Elongating Pol II associates with Spt6, COMPASS and FACT [adapted from Carrozza et al. (2003)].
Before Pol II reaches a histon, FACT mediates the deposition of the histone H2A–H2B heterodimers. Af-
ter the transcribing Pol II has passed, both Spt6 and FACT reassemble the histone structure. While Spt6
reinserts histone H3–H4 heterodimers, FACT reconstitutes H2A–H2B. Set1-dependent H3K4 trimethy-
lation (COMPASS) recruits Nrd1 and initiates the Nrd1-Nab3-Sen1 pathway (Terzi et al., 2011).
1.2.4 Spliceosome recruitment and pre-mRNA splicing
Unlike most eukaryotic genomes, the S. cerevisiae genome consists of a few introns only (95 % of
genes are intronless) (Neuvglise et al., 2011). Compared to the human system, the yeast ’intronome’
is smaller on average, primarily located near the 5’-end of a gene, and predominantly limited to one
intron per gene (Woolford and Peebles, 1992; Neuvglise et al., 2011; Will and Lhrmann, 2011).
Intron recognition by the spliceosome is the initial step in pre-mRNA splicing and was extensively
studied in vitro by Will and Lhrmann (2011). Spliceosome recruitment is triggered by intron-specific
key sequences as well as histone and CTD modifications during transcription (Morris and Greenleaf,
2000; Shieh et al., 2011).
Briefly, splicing begins with binding of the branch point (BP)-binding protein (BBP) (Msl5) to the
BP and binding of U2AF65 (Mud2) to a pyrimidine-rich region between the BP and 3’-splice site (3’-
SS), and continues with binding of the U1 nuclear ribonucleoproteins (snRNP) to the 5’-SS (Will and
Lhrmann, 2011). The resulting complex E is remodeled, and the small nuclear RNA (snRNA) of the
U2 snRNP displaces BBP by base pairing with the BP region, positioning U2 snRNP near the 3’-SS
and giving rise to complex A. After the recruitment of the U4/U6.U5 tri-snRNP complex, the non-
catalytic A complex is transformed into a pre-catalytic B complex (Boehringer et al., 2004). Due to
major rearrangements, the U4/U6 interaction is disrupted and the U6 snRNA replaces the U1 snRNP
complex at the 5’-SS. Following, the U1 and U4 snRNPs are dismissed, and the B complex becomes
active by catalyzing the first transesterification, performed by U6/U2 snRNPs (Wolf et al., 2009). This
consequently leads to the formation of the C complex and the second transesterification (Tseng and
Cheng, 2013). Finally, adjoining exons are covalently ligated, and the resulting intron lariat is released
together with the bound U2, U5, and U6 snRNP.
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1.2.5 mRNP export is deeply linked to 3’-end processing
In S. cerevisiae, the 3’-end mRNA processing machinery consists of over 20 different proteins in sev-
eral subcomplexes (Mandel et al., 2008). Each subcomplex recognizes and binds a specific sequence
element within the 3’-untranslated region (3’-UTR). Hrp1 and Nab4, which form the cleavage factor IB
(CFIB), are described to initially interact with the AU-rich efficiency elements to facilitate precise iden-
tification of the cleavage and polyadenylation (pA) site (Guo et al., 1995; Leeper et al., 2010; Mischo
and Proudfoot, 2013). The cleavage factor IA (CFIA) complex recognizes the A-rich positioning el-
ement, commonly located 10–30 nt upstream of the pA (Guo et al., 1995; Dichtl and Keller, 2001;
Leeper et al., 2010). The main cleavage and polyadenylation factor (CPF) complex comprises a core
structure including the poly(A) polymerase Pap1, the polyadenylation factor (PFI), cleavage factor II
(CFII) and six additional proteins, termed as APT (Figure 1.5) (Nedea et al., 2003; Mandel et al.,
2008). Recruitment of these complexes or single proteins occurs via binding to those specific mRNA
elements and the phosphorylated CTD (Section 1.2.1) (Minvielle-Sebastia et al., 1994; Komarnitsky
et al., 2000; Meinhart and Cramer, 2004). While the CFIA complex binds the CTD through the con-
served CTD interaction domain (CID) of Pcf11 (Sadowski et al., 2003), the CFII complex uses its factor
Cft1 to couple elongation and pA site recognition (Dichtl et al., 2002). Additional studies demonstrate
further connections of the 3’-end processing to histone modification, mRNA splicing, and/ or mRNA
export (Hirose and Manley, 2000).
Rna15
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Figure 1.5: The 3’-end mRNA processing machinery of S. cerevisiae [adapted from Nedea et al. (2003)]. The
orange and yellow ellipses symbolize the CPF (incl. PFI) and CFII complex, respectively. The rectangle
represents the APT complex with its two subcomplexes (dashed circles), connected through Pti1. The
factor Pta1 is required for bridging CPF/CFII to APT, and is a component of both complexes. Also Swd2
is found in both the APT and COMPASS complex (blue circle). Recruitment of Swd2 to the APT/CPF
is done by Ref2. The cleavage factor IA (green) and the cleavage factor IB (rose) are depicted on the
right. Double-headed arrows display known interactions.
Export of mRNA requires packing into messenger ribonucleoprotein particles (mRNPs) (Strsser
et al., 2002). These mRNPs are then bound by the THO/TREX complex and exported through the nu-
clear pore complex (NPC) into the cytosol (Strsser et al., 2002). Briefly, the DEAD-box helicase Sub2,
already bound to the nascent transcript, binds Hpr1 and recruits Mex67 by binding its C-terminal
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ubiquitin-associated (UBA) domain (Jensen et al., 2001). Mex67 principally acts as key to unlock the
nuclear envelop (Segref et al., 1997; Reed and Hurt, 2002). Binding of Mex67 to Yra1 has been pro-
posed to displace Sub2 (Reed and Hurt, 2002). It is assumed that the THO/TREX factors coordinate
transcription elongation and 3’-end processing as well as final transcript release and R-loop preven-
tion (Jimeno et al., 2002; Rougemaille et al., 2008; Gmez-Gonzlez et al., 2011).
Mex67 itself has a low intrinsic affinity and therefore requires mRNA-binding adaptors to carry its
cargo through the NPC (Rodrguez-Navarro and Hurt, 2011). Protein-protein interactions are medi-
ated by its N-terminal ribonucleoprotein (RNP) domain (Liker et al., 2000), whereas the UBA domain
promotes NPC-binding and co-transcriptional recruitment (Dieppois et al., 2006; Hobeika et al., 2007).
The phosphorylation state of the Mex67 adapter Npl3 depends on Glc7, a component of the APT sub-
complex (Gilbert and Guthrie, 2004). The stability of the APT on the other hand is ensured by correct
ubiquitylation of Swd2, controlled by histone H2B modification (COMPASS complex). Ubiquitylated
Swd2 promotes correct recruitment of Mex67 to its UBA domain by coupeling the APT subcomplex
to the nuclear export machinery (Figure 1.5) (Vitaliano-Prunier et al., 2012). Besides the CFIB factor
Hrp1, the Mex67 adaptor and poly(A)-binding protein Nab2 influence cleavage and polyadenylation as
well as mRNA packaging and nuclear surveillance (Anderson et al., 1993; Green et al., 2002; Hec-
tor et al., 2002; Tuck and Tollervey, 2013). Furthermore, Yra1 demonstrates a crucial and previously
unrecognized involvement in coupling the 3’-end maturation with nuclear mRNA export by directly
interacting with Pcf11 (Figure 1.5) (Johnson et al., 2009).
1.2.6 Termination of transcription and mRNA decay
During the productive elongation phase, Tyr1 is constantly held in a phosphorylation state (Y1P) to
prevent recruitment of the termination machinery (Figure 1.2) (Heidemann et al., 2013). When Pol II
approaches the pA site, Tyr1 gets dephoshorylated and thus allows the recruitment of Pcf11, which
initiates the subsequent termination process (Mayer et al., 2012). After Pol II has passed the pA site,
the RNA is cleaved by the putative endoribonuclease Ysh1, promoted by the CFIA factor Rna15 (Birse
et al., 1998). Following, the poly(A) polymerase Pap1 polyadenylates the pre-mRNA, which can then
be exported to the cytosol for translation and ultimate degradation (Figure 1.6B).
Termination and release of Pol II is either triggered by destabilization through conformational changes
of the Pol II EC after transcribing the pA site (’allosteric model’) or caused by the 5’→3’ exonuclease
Rat1 (human Xrn2), which interacts with the RNA-helicase Sen1 to degrade the transcript and finally
collides with the EC that may consequently induce termination (’torpedo model’) (Figure 1.6A) (Logan
et al., 1987; Kim et al., 2004c; Kawauchi et al., 2008). In contrast to mRNA, termination of ncRNAs de-
pends on the early termination factor Nrd1 that either can directly bind to mRNA or to the CTD via its
CTD interaction domain (CID) (Steinmetz and Brow, 1996; Creamer et al., 2011). Nrd1 preferentially
binds RNA motifs, which are enriched in ncRNAs and depleted in mRNAs except in some mRNAs
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whose synthesis is controlled by transcription attenuation (Schulz et al., 2013). Depletion of Nrd1 from
the nucleus results in Nrd1-unterminated transcripts (NUTs) that can deregulate transcription and dis-
turb promoter directionality (Schulz et al., 2013).
Ultimate degradation is initiated by the deadenylation process performed by the Ccr4-Not complex
(Chen and Shyu, 2011). The shortened 3’-end triggers both decapping by Dcp1/Dcp2 and exosome-
mediated 3’–5’ exonucleolytic decay. The 5’–3’ exonucleolytic decay, which is performed by Xrn1,
starts right after the complete removal of the cap structure by the decapping complex (Figure 1.6B).
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Figure 1.6: Eukaryotic ’torpedo’ termination and decay mechanisms [adapted from Decker and Parker (2002)
and Luo et al. (2006)]. A. The torpedo model. Endonucleolar cleavage (scissor) at the pA site creates
an entry site for the 5’–3’ exonuclease Rat1 that degrades until it collides with the elongating Pol II. The
direct contact or the short nascent RNA may consequently trigger the release of Pol II. B. Final decay
of mRNA is initiated by deadenylation by the Ccr4-Not complex, which can then trigger decapping (by
Dcp1/Dcp2) and exosome-mediated decay. Two general mRNA decay pathways exist: The 5’–3’ exonu-
clease digestion by Xrn1 (requires decapping) and the 3’–5’ exonuclease digestion by the exosome.
1.3 Target recognition of RNA-binding proteins (RBPs)
Supposingly, about 600 annotated RBPs, possessing several well-defined RNA-binding domains (RBDs),
are encoded in the budding yeast Saccharomyces cerevisiae (Hogan et al., 2008). These RBPs asso-
ciate with sets of RNAs at both a particular stage during the cell cycle (Dreyfuss et al., 2002; Moore,
2005) and at a similar localization (Hogan et al., 2008). Structural diversity of RBPs and target recog-
nition of RBDs are a function of the type, number, and arrangement of RBDs, helping RBPs to attain
specificity and high affinity for an (m)RNA sequence (Lunde et al., 2007). Several RBDs are currently
recognized including the RNA-recognition motif (RRM), Zinc finger (ZF), K-homology (KH) domain,
and double-stranded RBD (dsRBD) (Table 1.2 and Figure 1.7).
23
1 Introduction
Table 1.2: Topology of the most prominent RNA-binding domains. The typical RNA-recognition motif (RRM)
consists of four anti-parallel beta-sheets and two alpha-helices, whereas a third alpha-helices can be
included during RNA binding. Two different types of the K Homology (KH) domain are known, referred to
as type I and type II. While type I domains are mainly found in eukaryotes, type II domains predominantly
exist in prokaryotes. By far the best-characterized class of zinc fingers is the Cys2His2-like fold group
(C2H2). Double stranded RNA-binding domains (dsRBDs) recognize secondary structures of RNAs and
are mainly found in post-transcriptional gene regulation.
Domain Amino acids Topology Citations
RRM 90 β1-α1-β2-β3-α2-β4 Sachs et al. (1987)
KHtype-1 70 β1-α1-α2-β2-β3-α4 Musco et al. (1997)
KHtype-2 70 α1-β1-β2-α2-α3-β3 Grishin (2001)
ZFC2H2 30 [β1-β2-α1 + Zn2+]2 Miller et al. (1985)
dsRBD 65 α1-β1-β2-β3-α2 Bycroft et al. (1995)
The direct binding of RBDs to RNA targets can be limited by either too short recognition sequences
or greater distances between essential target sites. While several RBPs are restricted due to only one
RBD, many RBPs consist of multiple domains that can be modulated precisely through either combi-
nations of different kinds of RBDs or a certain number of domain repeats (i.e. the ZF tandem domain,
Figure 1.7). Thus, RBPs are able to interact with a much larger RNA surface and therefore increase
their specificity as well as affinity for long stretches of continuous or even discontinuous RNA targets
(Lunde et al., 2007; Chen and Varani, 2013). Additionally, flexible linker sequences between RBDs en-
able the recognition of RNA target sites over long distances, even allowing RBDs to bind to separated
target sites (Figure 1.8) (Conte et al., 2000). Resulting intra-molecular interactions, including electro-
static interactions, shape complementarity, and hydrogen bonding lead to conformational changes that
can significantly increase the binding to adjacent RNA (Conte et al., 2000; Lunde et al., 2007).
Figure 1.7: Examples of known RBD structures bound to RNA [adapted form Lunde et al. (2007)]. Depicted are
the N-terminal RNA-recognition motif (RRM) of human U1A, the K Homology (KH) domain of Nova-2,
two zinc fingers (ZFs) of the AU-rich element binding protein TIS11d, and the dsRBD of yeast’s nuclear
dsRNA-specific ribonuclease Rnt1 (alias RNase III). Alpha-helices and beta-sheets are colored in red
and yellow, respectively. The RNA backbone is depicted as orange ribbon, and the zinc atoms of the ZF
structure is highlighted in purple.
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Figure 1.8: Multi-domain conformations increase RNA-binding affinity [adapted from Lunde et al. (2007) and
Mackereth et al. (2011)]. A. Scheme of modular RNA-binding domains that can be arranged to recognize
a long RNA sequence (left), separated target sites (centre), and/or RNAs that belong to different target
molecules (right). Both domains are connected by a linker (grey). B. Arrangement of the tandem RNA
recognition motif (RRM) domains of the human U2 snRNP auxiliary factor (U2AF65) after binding to a
polypyrimidine tract (depicted in orange).
1.4 Cross-linking and immunoprecipitation (CLIP)
One of the first approaches to identify target-specific ligands (ssDNA or RNA) in vitro came up in the
early 1990s, termed as ’Systematic evolution of ligands by exponential enrichment’ (SELEX) (Tuerk
and Gold, 1990). The first method to localize binding sites of RBPs in vivo, referred to as ’cross-linking
and immunoprecipitation’ (CLIP), was introduced by Ule et al. (2003). CLIP uses UV light at 254 nm
to cross-link cells or tissues prior to cell lysis to avoid post-lysis interactions (Ule et al., 2003). The
energy of the UV254 light introduces a covalent bond between the protein of interest and the target
RNA. The protein-RNA complex can be isolated through immunoprecipitation and SDS-PAGE. Cross-
linked RNAs are trimmed by RNase digestion and bound RNA fragments are released by reverse
cross-linking (by proteinase K treatment). Following 3’ and 5’ adapter ligation, the reverse transcription
(RT) is performed to generate cDNA libraries that are finally amplified and sequenced (Ule et al.,
2003, 2005). During the RT, deletions are introduced at the cross-link site (Figure 1.9), which are
more reliable in comparison to possible point mutations (Zhang and Darnell, 2011). Furthermore,
it was shown by Zhang and Darnell (2011) that cross-links exclusively emerge at RNA target sites
containing a uridine, indicating that either adenosines, cytidines and/ or guanosines are not ’clipable’
or that the reverse transcriptase (RTase) cannot overcome these nucleosides.
1.4.1 CLIP-based methods and their specifications
Nowadays, many variants of the original CLIP protocol from Ule et al. (2003) exist. With the development
of next-generation sequencing (NGS) platforms, the ”high-throughput era” was finally initiated allowing
much more complex and sophisticated studies. The combination of CLIP with NGS resulted in ’High-
throughput sequencing CLIP’ (or HITS-CLIP) that allowed the identification of RNA-binding sites in
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a transcriptome-wide manner by comparing clustered sequence reads with specific negative controls
(Figure 1.11) (Licatalosi et al., 2008). In 2010, two advanced CLIP variants were introduced by Knig
et al. (2010) and Hafner et al. (2010) referred to as ’Individual-nucleotide resolution CLIP’ (iCLIP) and
’Photoactivatable ribonucleoside-enhanced CLIP’ (PAR-CLIP), respectively. Compared to the original
CLIP, both now ensured a single-nucleotide resolution without the need of negative controls by using
two widely different approaches (Figure 1.11). While iCLIP relies on a modified cDNA library prepa-
ration based on circularization and frequent reverse transcriptase termination events at the cross-
linked site (Knig et al., 2010), PAR-CLIP uses photo-reactive nucleotides (such as 4-thiouridine or 4-
thiouracil) and UV light at 365 nm for the cross-linking reaction, which increases the incidence of point
mutations at the cross-link sites (Hafner et al., 2010; Creamer et al., 2011; Ascano et al., 2012) (Fig-
ure 1.9 and Section 1.4.1). Additionally, iCLIP was shown to be performed with double-tagged RBPs
using stringent tandem affinity purification (TAP) instead of an immunoprecipitation, termed as ’Individ-
ual nucleotide resolution UV-crosslinking and affinity purification’ (iCLAP) (Wang et al., 2010). Another
CLIP approach that uses TAP similar to iCLAP is the ’Crosslinking and cDNA analysis’ (CRAC) devel-
oped from Granneman et al. (2009).
A
B
RT primercDNA
cross-linked RNARTase
C
L
IP
P
A
R
-C
L
IP
cross-link site
Figure 1.9: Fundamental distinction between UV cross-linking with 254 and 365 nm [adapted from Ascano
et al. (2012)]. UV light cross-linking introduces a covalent cross-link between a nucleoside and an
aromatic side chain amino acid (Tyr, Phe, and/or Trp). Whereas the protein is absolutely digested during
the CLIP/ PAR-CLIP protocol, the cross-linked adduct remains at the nucleoside. A. CLIP uses 254 nm
that connects the amino acid to position 5 of the nucleobase uracil (U). During reverse transcription the
reverse transcriptase (RTase) stalls at this position, but is also able to skip the cross-link site resulting
in a base deletion. B. PAR-CLIP uses 365 nm that established a covalent cross-link between the amino
acid and the thio group of the 4-thiouridine (4sU). Compared to CLIP, the RTase reads through the
position and mistakenly incorporates a guanosine (G) instead of an adenosine (A), which leads to the
characteristic T-to-C transitions after cDNA library preparation defining the sites of cross-linking.
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1.4.2 Photoactivatable ribonucleoside-enhanced CLIP
Most CLIP-related procedures (Section 1.4.1) use rigorous and stringent washes to biochemically
reduce occurring background binding. PAR-CLIP uses photo-reactive ribonucleotides to address this
problem (Hafner et al., 2010). These analogues are added to the growth medium, which are then
randomly taken up by cells and eventually incorporated into nascent RNAs in a transcriptome-wide
manner. Predominantly, the photoactivatable substrates 4-thiouridine (4sU) and 4-thiouracil (4tU) are
used for in vivo RNA labeling in the human and yeast system, respectively (Ascano et al., 2012;
Sun et al., 2012). Similar analogs like 6-thioguanosine (6sG), 5-iodouridine (5iU) and 5-bromouridine
(5BrU) have been additionally assayed by Hafner et al. (2010) (Figure 1.10), but showed lower cross-
linking efficiencies compared to 4sU. Both the efficiency of nucleoside uptake and the potential toxicity
varies between cell types (Lozzio and Wigler, 1971). However, incorporation of 4sU or 4tU is restricted
to U-containing regions within the transcript.
5-bromouridine (5BrU)5-iodouridine (5iU)6-thioguanosine (6sG)
OHOH
Figure 1.10: Structures of photoactivatable nucleosides. The photo-reactive groups are encircled.
Another critical step in the PAR-CLIP procedure is the in vivo UV light cross-linking at 365 nm,
a long-wavelength where natural nucleotides no longer cross-link. Compared to related CLIP ap-
proaches (Section 1.4.1), decreasing the wavelength to 365 nm has three main advantages in relation
to 254 nm (CLIP): (i) less UV damage using the same amount of radiation energy (Gaillard and Aguil-
era, 2008; Ascano et al., 2012), (ii) an improved RNA recovery up to 1000-fold applying photoactivat-
able nucleosides (Hafner et al., 2010), and (iii) high-resolution binding sites due to PAR-CLIP-specific
T-to-C transition, which results from the incorporated base analogue (Hafner et al., 2010; Spitzer et al.,
2014). Compared to CLIP, the RTase reads through the site of cross-linking and mistakenly incorpo-
rates a guanosine instead of an adenosine, which leads to the characteristic U-to-C transitions during
reverse transcription that, when mapped to the genome, manifest themselves as T-to-C mismatches
(Figure 1.9B) (Ascano et al., 2012). During the bioinformatics, this transition is used to distinguish
between true and false cross-linking events, and enables a much more precise identification of RBP
binding sites. Other possible sources of nucleotide mismatches are sequencing errors and differences
between the genome sequence of the organisms used in PAR-CLIP experiments and the reference
sequence onto which the PAR-CLIP reads are mapped. However, these mismatches can be easily
identified and computationally eliminated during the data analysis.
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Figure 1.11: Comparison of the original (HITS-)CLIP with the PAR-CLIP and iCLIP variants [copied from Knig
et al. (2011)]. Cells are irradiated with UV light at 254 nm (HITS-CLIP/iCLIP) and 365 nm (PAR-
CLIP) that induces the formation of covalent cross-links between RNA-binding protein (RBP) and the
RNA (light blue). Photoactivatable ribonucleoside-enhanced (PAR)-CLIP uses photo-reactive ribonu-
cleotides (i.e. 4-thiourdine) to increase cross-linking efficiency (the analogue is depicted as red circle).
Cells are lysed, bound RNAs are partially digested, and the protein–RNA complexes are immunopre-
cipitated. While HITS-CLIP’s library preparation is based on a deletion or mutation at the cross-link site
(middle panel), individual-nucleotide resolution CLIP (iCLIP) relies on a modified cDNA library prepara-
tion based on circularization and frequent reverse transcriptase termination events at the cross-linked
site (right panel). Due to the incorporated 4-thiourdine, in PAR-CLIP the reverse transcriptase reads
through the site of cross-linking and mistakenly incorporates a guanosine instead of an adenosine,
which leads to the characteristic U-to-C transitions during reverse transcription that, when mapped to
the genome, manifest themselves as T-to-C mismatches.
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1.5 Aims and scope of this thesis
The RNA molecule does not only pass genetic information from DNA to protein, it has crucial roles in
biological systems by regulating various biological processes (Ferr-D’Amar and Scott, 2010; Will and
Lhrmann, 2011). From an evolutionary point of view, RNA is supposed to be the older, primordial
molecule that preceded the contemporary DNA- and protein-based life on Earth (Section 1.1) (Woese
et al., 1966; Crick, 1968). Despite the ability of RNA molecules to accomplish sophisticated reac-
tions without protein-based enzymes, modern RNAs are commonly found in association with RNA-
binding proteins (Cech, 1986; Moore and Steitz, 2011). Those RBPs associate with RNAs through
their RNA-specific binding domains (Section 1.3) (Conte et al., 2000). Especially during mRNA bio-
genesis, RBPs are involved in pre-mRNA synthesis by RNA polymerase II and co-transcriptional RNA
processing (Sections 1.2). Mapping of mRNP biogenesis factors onto pre-mRNA and mature mRNA
promises insights into RNA determinants for splicing, 3’-processing, and RNA export, but also into
the coupling between these processes. RBPs can in principle be mapped onto the transcriptome by
in vivo protein-RNA cross-linking and immunoprecipitation (CLIP) (Section 1.4) (Ule et al., 2003), and
can indeed provide transcriptome-wide maps for several biogenesis factors.
Consequently, the first aim of this work was the establishment of the recent CLIP technique in the
yeast system, referred to as Photoactivatable ribonucleoside-enhanced (PAR)-CLIP (Hafner et al.,
2010). It takes advantage of diagnostic T-to-C conversions that occur during reverse transcription
as a result of a photo-reactive ribonucleotide being covalently cross-linked to the protein of interest,
thus enabling direct protein–RNA interactions to be distinguished from indirect non-cross-linked in-
teractions (Section 1.4.2) (Ascano et al., 2012). For this purpose, several investigations had to be
planned and established to finally get a cutting-edge protocol with high resolution (Section 5.1). Espe-
cially the RNA labeling and UV light cross-linking represent crucial steps in the PAR-CLIP procedure
and were intensively tested and adapted (Section 5.1.1 to 5.1.3).
Because almost no mature computational pipeline for PAR-CLIP data analysis in S. cerevisiae was
known by this time, a specifically adapted and powerful pipeline for data analysis had to be designed
and implemented, allowing faster processing with the highest possible accuracy (Section 5.2). To
achieve this goal, parts of this work were performed in cooperation with Phillipp Torkler (AG Söding)
and Alexander Graf (AG Blum). To calculate p-values for true cross-linking sites, a null hypothesis had
to quantitatively be modeled and tested to finally distinguish between a true T-to-C transition, observed
from a real cross-link event, and a false mismatch. This tailored pipeline was supposed to combine
both a transparent and powerful tool for analyses of sequencing data obtained from PAR-CLIP exper-
iments and a graphical user interface (GUI) for user-friendly applications.
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Not all transcripts are equally expressed during the cell cycle (Xu et al., 2009; Pelechano et al., 2013).
In chromatin immunoprecipitation (ChIP) experiments, data is necessarily normalized by using both an
input reference and a mock immunoprecipitation control (Mayer et al., 2010). To reduced transcript-to-
transcript signal fluctuation, resulting from RNAs with different abundance, a way to normalize CLIP
data had to be found and included into the bioinformatics. To achieve this aim, expression levels after
RNA labeling and UV treatment should be assayed applying both microarray analysis and RNA-Seq
(Section 5.3.1).
However, mRNP biogenesis factors have not been systematically mapped onto pre-mRNAs, likely due
to difficulties in trapping short-lived RNAs in cells, and due to the complexity caused by the large va-
riety of pre-mRNA species. Consequently, one initial aim was the clipping and mapping of biogenesis
factors onto the newly synthesized yeast transcriptome, including factors that are involved transcrip-
tion, splicing, and 3’-processing of pre-mRNAs, as well as in the assembly of mature messenger
ribonucleoprotein (mRNP) complexes for nuclear export. Resulting data was supposed to provide new
insights into mRNP biogenesis and therefore helps to understand how those factors recognize pre-
mRNA elements and specific target regions in vivo. Thus, the overall impact of the macromolecule
RNA and its ’hidden’ elements and functions might be decoded, demonstrating the influence and im-
portance of RNAs in coordination with the transcription cycle as well as post-transcriptional processes
in the budding yeast S. cerevisiae.
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2.1 Chemicals
Table 2.1: List of chemicals used in this thesis.
Manufacturer Chemical CAS Order number
Sigma-Aldrich1 4-Thiouracil 591-28-6 440736
4-Thiouridine 13957-31-8 T4509
6-Thioguanine 154-42-7 A4882
6-Thioguanosine 345909-25-3 858412
Adenosine 58-61-7 A9251
Acetonitrile 75-05-8 34998
Citric acid 77-92-9 251275
Cytidine 65-46-3 C122106
Dithiothreitol 3483-12-3 43815
Ethanol 64-17-5 32205
Guanosine 118-00-3 G6752
NP-40 9036-19-5 NP40S
Magnesium chloride hexahydrate 7791-18-6 63072
Sodium acetate 127-09-3 S2889
Sodium chloride 7647-14-5 S7653
Sodium deoxycholate 302-95-4 D6750
Sodium dodecyl sulfate 151-21-3 71736
Sodium phosphate dibasic 7558-79-4 S3264
Acetic acid triethylamine 5204-74-0 09748
Triton X-100 9002-93-1 93443
Thymidine 50-89-5 T9250
neoLab2 Benzamidine hydrochloride 1670-14-0 14830.0005
Leupeptin hemisulfate 103476-89-7 12005.0025
Pepstatin A 26305-03-3 11645.0010
Phenylmethanesulfonyl fluoride 329-98-6 16350.0005
Table 2.1: – continued on next page
1Sigma-Aldrich Corporation, St. Louis, MO 63103, USA; website: http://www.sigma-aldrich.com
2neoLab Migge Laborbedarf-Vertriebs GmbH, Heidelberg, 69123, Germany; website: http://www.neolab.de
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Table 2.1: – continued from previous page
Manufacturer Chemical CAS Order number
Merck3 Sodium phosphate dibasic dihydrate 10028-24-7 1065801000
Potassium dihydrogen phosphate 7778-77-0 1048731000
Potassium chloride 7447-40-7 1049380500
Potassium hydroxide 1310-58-3 1050331000
Carl Roth4 Dimethyl sulfoxide 67-68-5 7029.1
Ethylene glycol tetraacetic acid 67-42-5 3054.2
Glycerol 56-81-5 3783.1
HEPES 7365-45-9 9105.3
Ethylenediaminetetraacetic acid 60-00-4 CN06.1
Skim milk powder 68514-61-4 T145.1
Tween20® 9005-64-5 9127.1
Serva5 Bromophenol Blue Na-salt 34725-61-6 153751
2.2 TAP-tagged strains
The Open Biosystems, Inc. (Thermo Scientific6) Yeast-TAP Tagged ORF library was used containing C-
terminally tagged proteins of the Saccharomyces cerevisiae BY4741 strain. The C-terminal TAP consists
of a calmodulin binding peptide, a TEV cleavage site, and two IgG binding domains of Staphylococcus
aureus protein A. Table 2.2 lists all tagged proteins that were applied in this thesis with systematic name
and library coordinate.
Table 2.2: List of TAP-tagged strains used in this thesis.
Tagged protein Systematic name Plate Well
Cbc2 YPL178W 7GS2 E4
Cft2 YLR115W 2GS3 C1
Gbp2 YCL011C 6GS3 D3
Hpr1 YDR138W 4GS4 C3
Hrb1 YNL004W 6GS3 C11
Table 2.2: – continued on next page
3Merck KGaA, Darmstadt, 64293, Germany; website: http://www.merckgroup.com
4Carl Roth GmbH + Co. KG, Karlsruhe, 76231, Germany; website: http://www.carlroth.de
5SERVA Electrophoresis GmbH, Heidelberg, 69123, Germany; website: http://www.serva.de
6Fisher Scientific - Germany GmbH, Schwerte, 58239, Germany; website: http://www.thermoscientificbio.com
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Table 2.2: – continued from previous page
Tagged protein Systematic name Plate Well
Ist3 YIR005W 12GS4 C7
Luc7 YDL087C 9GS3 G1
Mex67 YPL169C 4GS3 A9
Mpe1 YKL059C 8GS4 A6
Msl5 YLR116W 5GS3 F4
Mud1 YBR119W 8GS3 C11
Mud2 YKL074C 4GS3 G11
Nab2 YGL122C 3GS2 E5
Nab3 YPL190C 1GS2 G12
Nam8 YHR086W 4GS3 H4
Npl3 YDR432W 1GS1 H1
Nrd1 YNL251C 1GS1 D8
Pab1 YER165W 1GS1 D6
Pub1 YNL016W 1GS1 F10
Rna15 YGL044C 6GS2 C2
Snp1 YIL061C 10GS4 A10
Sub2 YDL084W 1GS1 F12
Tho2 YNL139C 1GS4 C2
Yth1 YPR107C 11GS3 A5
2.3 Buffers and Media
Buffers and media used in this thesis are listed in Table 2.3 and Table 2.4, respectively.
Table 2.3: Buffer compositions
Buffer Composition
PBS buffer (1x) 137 mM NaCl
2.7 mM KCl
10 mM Na2HPO4
2 mM KH2PO4
TBE buffer (1x) 89 mM Tris base
20 mM EDTA (pH 8.0)
8 mM Boric acid
Table 2.3: – continued on next page
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Table 2.3: – continued from previous page
Buffer Composition
Lysis buffer 50 mM Tris-HCl (pH 7.5)
100 mM NaCl
0.1 % (v/v) SDS
0.5 % (v/v) NP-40
0.5 % (v/v) Na deoxycholate
Wash buffer 50 mM Tris-HCl (pH 7.5)
1 M NaCl
0.1 % (v/v) SDS
0.5 % (v/v) NP-40
0.5 % (v/v) Na deoxycholate
T1 buffer 50 mM Tris-HCl (pH 7.5)
2 mM EDTA
Phosphatase reaction buffer (pH 6.5) 50 mM Tris-HCl (pH 7.0)
1 mM MgCl2
100 mM ZnCl2
Phosphatase wash buffer 50 mM Tris-HCl (pH 7.5)
20 mM EGTA
0.5 % (v/v) NP-40
Polynucleotide kinase (PNK) buffer 50 mM Tris-HCl (pH 7.5)
50 mM NaCl
10 mM MgCl2
Proteinase K buffer 50 mM Tris-HCl (pH 7.5)
75 mM NaCl
6.25 mM EDTA
1 % (v/v) SDS
SDS-PAGE loading buffer (2x) 100 mM Tris-HCl (pH 6.8)
4 mM EDTA
20 % (v/v) Glycerol
200 mM DTT
4 % (v/v) SDS
0.02 % (w/v) Bromophenol blue
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Table 2.4: Media compositions
Medium Composition
YPD medium 1 % Yeast extract (w/v)
2 % Peptone (w/v)
2 % Glucose (w/v)
for YPD-Agar plus 2 % Agar (w/v)
SC medium 10 mg/l Adenine, Uracil
20 mg/l L-Methionine, L-Histidine HCl, L-Methionine
50 mg/l L-Arginine, L-Isoleucine, L-Lysine HCl, L-Tryptophan,
L-Tyrosine, L-Phenylalanine
80 mg/l L-Aspartic acid
100 mg/l L-Leucine, L-Threonine, 4-Thiouracil
140 mg/l Valine
6.9 g/l Yeast Nitrogen Base
2 % Glucose (w/v)
2.4 Commercial buffers and Reagent systems (Kits)
Commercial buffers and reagent kits used in this thesis are listed in Table 2.5 and Table 2.6, respectively.
Table 2.5: Commercial buffers.
Manufacturer Buffer Order number
Fermentas7 T4 PNK Reaction Buffer A EK0031
10x TURBO™ DNase buffer EN0541
Invitrogen8 5X First-Strand Buffer 18080-044
NEB9 Antarctic Phosphatase Reaction Buffer M0289S
Rnal2tr ligase buffer M0351S
T4 RNA Ligase 1 Reaction Buffer (10X) B0204
Sigma-Aldrich10 TRI Reagent® RNA Isolation Reagent T9424
7Fermentas GmbH, St. Leon-Rot, 68789, Germany; website: http://www.fermentas.de
8Invitrogen GmbH, Karlsruhe, 76131, Germany; website: http://www.invitrogen.com
9New England Biolabs GmbH, Frankfurt, 65929, Germany; website: http://www.neb-online.de
10Sigma-Aldrich Corporation, St. Louis, MO 63103, USA; website: http://www.sigma-aldrich.com
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Table 2.6: Commercial reaction systems (Kits).
Manufacturer Kit Order number
Affymetrix11 GeneChip® 3’ IVT Express Kit
GeneChip® Hybridization Kit
Illumina12 MiSeq Reagent Kits v2 (50-cycles) MS-102-2001
TruSeq SR Rapid Cluster Kit v3 GD-402-4001
TruSeq Rapid SBS reagent kit v3 (50-cycles) FC-402-4002
cBot Single-Read Cluster Generation Kit GD-300-1001
TruSeq SBS reagent kit v2-GA (36-cycles) FC-104-5001
NuGEN13 Encore Complete RNA-Seq Library Systems 0311
RNA-Seq DR Multiplex System 1-8 0333
PeqLab14 KAPAHiFi™ PCR Kit 07-KK2100-01
Qiagen15 QIAquick Gel Extraction Kit 28704
2.5 Enzymes
Table 2.7: Enzymes used in this thesis.
Manufacturer Enzyme Activity Order number
Fermentas16 RNase T1 1,000 U/ µl EN0541
T4 Polynucleotide Kinase 10 U/ µl EK0031
NEB17 Antarctic Phosphatase 5 U/ µl M0289
T4 RNA Ligase 2 (K227Q) 200 U/ µl M0351
Proteinase K 20 mg/ ml P8102
T4 RNA Ligase 1 20 U/ µl M0204
Phusion HF DNA Polymerase 20,000U/ µl M0530
Invitrogen18 Bacterial Alkaline Phosphatase 150 U/ µl 18011-015
RNAse OUT™ 40 U/ µl 10777-019
SuperScript III RT 200 U/ µl 18080-093
Ambion® TURBO™ DNase 2 U/ µl AM2238
Table 2.7: – continued on next page
11Affymetrix UK Ltd., High Wycombe, HP10 0HH, United Kingdom; website: http://www.affymetrix.com
12Illumina, Inc., San Diego, CA, 92101, USA; website: http://www.illumina.com
13NuGEN Technologies, Inc., San Carlos, CA 94070, USA; website: http://www.nugen.com
14PEQLAB Biotechnologie GMBH, Erlangen, 91052, Germany; website: http://www.peqlab.de
15Qiagen N.V., Hilden, 40724, Germany; website: http://www.qiagen.com
16Fermentas GmbH, St. Leon-Rot, 68789, Germany; website: http://www.fermentas.de
17New England Biolabs GmbH, Frankfurt, 65929, Germany; website: http://www.neb-online.de
18Invitrogen GmbH, Karlsruhe, 76131, Germany; website: http://www.invitrogen.com
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Table 2.7: – continued from previous page
Manufacturer Enzyme Activity Order number
Sigma-Aldrich19 Phosphodiesterase I ≥0.40 U/ vail P3243
2.6 Oligonucleotide primer
Desalted oligonucleotide primer were mainly obtained from IDT20; whereas the common concentration
amounted between 25 nmole and 1µmole. For cDNA library preparation the oligonucleotide sequences
from the NEXTflex™ Small RNA Sequencing Kit (Bioo Scientific21, #5132-02) were used. The final
Fusion-PCR was performed using the NEXTflex™ Small RNA Barcode Set A (Bioo Scientific, #513301).
The entire set of used primer and barcodes respectively is listed in Table 2.8.
Table 2.8: Listed is the designation and sequence of each oligonucleotide primer. Specific modifications at the 5’ or
3’ end are marked by brackets: [App] = pre-adenylation, [ddC] = Dideoxy-C, and [Phos] = phosphorylation.
The position of the actual barcode sequence of the Barcode Fusion Primer is labeled as ”Barcode”.
Used barcode sequences are listed below containing the actual primer sequence (5’-3’) as well as the
reverse complement (c3’-c5’) which is finally sequenced. Furthermore a self-made DNA marker was used
for cDNA library preparation. Therefore three ssDNA oligonucleotide PCR templates were designed,
resulting in Fusion PCR products with a size of 118 nt, 140 nt and 180 nt. The black square marks the
additional insert of the Marker140 and Marker180, respectively.
Designation Primer sequence
Fwd-Not1-TAP 5’ - TTA CAT GTG GGC ATT GAA GC - 3’
Fwd-Nrd1-TAP 5’ - AAG ACA TGA GGC CGA AAA TG - 3’
Fwd-Mpt5-TAP 5’ - TCA ACC AAA ACG CAT ATC CC - 3’
Rev-universal-TAP 5’ - AAC CCG GGG ATC CGT CGA CC - 3’
3’ Adapter 5’ -[App]- TGG AAT TCT CGG GTG CCA AGG -[ddC]- 3’
5’ Adapter 5’ -[Phos]- GUU CAG AGU UCU ACA GUC CGA CGA UC - 3’
RT-Primer 5’ - CCT TGG CAC CCG AGA TTC CA - 3’
microRNA control 5’ -[Phos]- CUCAGGAUGGCGGAGCGGUCU - 3’
Universal Fusion Primer 5’ - AAT GAT ACG GCG ACC ACC GAG ATC TAC ACG TTC AGA ...
... GTT CTA CAG TCC GA- 3’
Barcode Fusion Primer 5’ - CAA GCA GAA GAC GGC ATA CGA GA -Barcode- GTG ACT ...
... GGA GTT CCT TGG CAC CCG AGA ATT CC- 3’
Nextera primer 1 5’ - AAT GAT ACG GCG ACC ACC GA - 3’
Nextera primer 2 5’ - CAA GCA GAA GAC GGC ATA CGA - 3’
Table 2.8: – continued on next page
19Sigma-Aldrich Corporation, St. Louis, MO 63103, USA; website: http://www.sigma-aldrich.com
20Integrated DNA Technologies, Inc., Coralville, Iowa 52241 USA; website: http://eu.idtdna.com
21Bioo Scientific Corp., Austin, Texas 78744, USA; website: http://www.biooscientific.com/
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Table 2.8: – continued from previous page
Designation Primer sequence
Barcode 1 5’ - TCGTGAT - 3’ −→ 3’ - ATCACGA - 5’
Barcode 2 5’ -TACATCG - 3’ −→ 3’ - CGATGTA - 5’
Barcode 3 5’ -TGCCTAA - 3’ −→ 3’ - TTAGGCA - 5’
Barcode 4 5’ -TTGGTCA - 3’ −→ 3’ - TGACCAA - 5’
Barcode 5 5’ -TCACTGT - 3’ −→ 3’ - ACAGTGA - 5’
Barcode 6 5’ -TATTGGC - 3’ −→ 3’ - GCCAATA - 5’
Barcode 7 5’ -TGATCTG - 3’ −→ 3’ - CAGATCA - 5’
Barcode 8 5’ -TTCAAGT - 3’ −→ 3’ - ACTTGAA - 5’
Barcode 9 5’ -TCTGATC - 3’ −→ 3’ - GATCAGA - 5’
Barcode 10 5’ -TAAGCTA - 3’ −→ 3’ - TAGCTTA - 5’
Barcode 11 5’ -TGTAGCC - 3’ −→ 3’ - GGCTACA - 5’
Barcode 12 5’ -TTACAAG - 3’ −→ 3’ - CTTGTAA - 5’
Marker118 5’ - CCT TGG CAC CCG AGA ATT CCA  GAT CGT CGG ACT GTA ...
... GAA CTC TGA AC- 3’
 Marker140 5’ - AGC ATG TCA AAT TGA TAA GGC G - 3’
 Marker180 5’ - AGC ATG TCA AAT TGA TAA GGC GAT GTA GTC CTT CAA ...
... AGT TCG TAA GAC CTC CTG ATT ATG CA- 3’
RNAdigest-Control 5’ - rCrGrUrArCrGrCrUrGrArA-rUrArGrUrUrUrArArArCrUrGrU - 3’
2.7 Consumables
Table 2.9: Special consumables that have been used in this thesis.
Consumables Manufacturer
Amersham Hyperfilms™ ECL GE Healthcare
NuPAGE® Novex 4-12 % Bis-Tris Mini Gels Life Technologies Ltd.
PVDF membrane Carl Roth GmbH + Co. KG
RNA Clean & Concentrator™5 Zymo Research
2 ml FastPrep tubes + Lids MP
0.5 ml DNA LoBind Tubes Eppendorf, Hamburg
1.5 ml DNA LoBind Tubes Eppendorf, Hamburg
2 ml DNA LoBind Tubes Eppendorf, Hamburg
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2.8 Equipment
Table 2.10: Equipment used in this thesis.
Designation Manufacturer
Centrifuge 5810R Eppendorf, Hamburg
Centrifuge 5424R Eppendorf, Hamburg
Vacuum centrifuge Concentrator plus Eppendorf, Hamburg
Sorvall Evolution RC superspeed Thermo Fisher Scientific GmbH, UlmC
en
tr
ifu
ga
tio
n
Rotor SLC-6000 Thermo Fisher Scientific GmbH, Ulm
Power Supply EPS 3501 Amersham Pharmacia Biotech Europe GmbH, Freiburg
Novex Mini Cell Invitrogen, Karlsruhe
PerfectBlue™ Horizontal Gel Systems PEQLAB Biotechnologie GMBH, Erlangen
Power Supply Model 200/2.0 Bio-Rad Laboratories GmbH, Munich
Agilent 2100 Bioanalyzer Agilent Technologies, Waldbronn
Experion Electrophoresis Station Bio-Rad Laboratories, Munich
E
le
ct
ro
ph
or
es
is
Trans-Blot® Turbo™ Transfer System Bio-Rad Laboratories GmbH, Munich
Affymetrix GeneChip® Scanner 3000 Affymetrix, England
GeneChip® Hybridization Oven 640 Affymetrix, England
HiSeq 1500 Illumina, Inc., San Diego
G
en
om
ic
s
Genome Analyzer IIx Illumina, Inc., San Diego
Programmable Solvent Module 126 Beckman System Cold, USA
Diode Array Detektor Module 168 Beckman System Cold, USAH
P
LC
Programmable Solvent Module 126 Beckman System Cold, USA
T Professional Basic Gradient Biometra GmbH, Göttingen
Thermocycler T3000 Biometra GmbH, Göttingen
Rotating wheel Labinco B.V., Netherlands
Rocking table STS Cat neoLab, Heidelberg
Rotamax 120 Heidolph Instruments GmbH & Co. KG, Schwabach
WTC Binder Incubator BINDER GmbH, Tuttlingen
Barnstead Lab-Line Titer Plate Shaker Thermo Fisher Scientific GmbH, Ulm
Thermomixer comfort 5436 Eppendorf, Hamburg
In
cu
ba
tio
n
Magnetic stirrer MR 3001 Heidolph, Schwalbach
Table 2.10: – continued on next page
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Table 2.10: – continued from previous page
Designation Manufacturer
White Light Transilluminator TW-26 UVP, Cambridge, England
Transilluminator Intas-Science Imaging Instruments GmbH, Göttingen
Gel Documentation System Intas-Science Imaging Instruments GmbH, Göttingen
Epson perfection 3200 photo Scanner EPSON Deutschland GmbH, Meerbusch
Image Eraser GE Healthcare Europe GmbH, Freiburg
Storm 860 GE Healthcare Europe GmbH, Freiburg
Microscope DMLS Leica Mikrosysteme Vertrieb GmbH, Wetzlar
Im
ag
in
g
Exposer Cassette GE Healthcare Europe GmbH, Freiburg
pH-Meter 766 Calimatic Knick, Berlin
NanoDrop 1000 PEQLAB Biotechnologie GmbH, Erlangen
AC 210 P Analytical balance MC1 Sartorius, Göttingen
LC 2200 P Analytical balance MC1 Sartorius, Göttingen
Dial-O-gram balance Ohaus Europe GmbH, Swiss
Qubit fluorometer Invitrogen, Karlsruhe
M
ea
su
re
m
en
t
BioPhotometer Eppendorf, Hamburg
Experion Priming Station Bio-Rad Laboratories, Munich
Vortex Mixer neoLab, Heidelberg
Microwave Siemens AG, Munich
M
is
ce
lla
ne
ou
s
Crosslinker Bio-Link BLX-365 PEQLAB Biotechnologie GMBH, Erlangen
FastPrep-24 MP Biomedicals Europe, France
Bioruptor Next Generation Sonication Diagenode, Lige
Mixer Mill MM 400 Retsch, HaanLy
si
s
Bioruptor Water Cooler Diagenode, Lige
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3.1 Cultivation of Saccharomyces cerevisiae
Cultivation of S. cerevisiae BY4741 strains was performed at 30 °C and 160 rpm using either Yeast Extract
Peptone Dextrose (YPD) or Synthetic complete (SC) medium supplemented with 2 % glucose. Therefore,
cells were plated on YPD agar and cultivated at 30 °C for 1-2 days. One colony was subsequently used
to inoculate a 30 ml YPD pre-culture. Cell density was photometrically determined using a spectrometer
at 600 nm. One optical density unit (OD600) corresponds to ~2.5 x 107 yeast cells.
3.2 TAP-tag validation by western blot analysis
Yeast strains containing TAP-tagged genes were tested for expression of the correct tagged protein by
western blotting. Therefore, the cell lysate of a 50 ml YDP culture was diluted 1:100 in lysis buffer, mixed
with one volume of 2x SDS loading buffer and incubated for 3 min at 95 °C. Subsequently, the sample
was spun for 30 sec at 500 rpm, immediately loaded and run on a pre-cast NuPAGE 4-12 % Bis-Tris gel
(Invitrogen). Following SDS-PAGE, samples were blotted onto a 0.2 µm polyvinylidene difluoride (PVDF)
membrane provided in the Trans-Blot® Turbo™ Transfer Pack by using the Trans-Blot® Turbo™ Transfer
System (Bio-Rad Laboratories, Inc.). The membrane was then blocked at room temperature for 30 min
in 20 ml PBS buffer with 5 % non-fat dry milk and 0.1 % Tween20. Five microliter of the primary PAP
antibody (Sigma-Aldrich) were diluted in 10 ml PBS buffer + 2 % non-fat dry and incubated with the
membrane for another hour. After three brief washing steps with 20 ml PBS buffer each, the membrane
was incubation in 20 ml PBS + 0.1 % Tween20 for 10 min, and finally rinsed with fresh tap water. Antibody
detection was performed using Pierce enhanced chemiluminescence (ECL) Western blotting substrate
(Thermo Scientific) in combination with Amersham Hyperfilm™ ECL (GE Healthcare).
3.3 PAR-CLIP
3.3.1 RNA labeling with 4-thiouracil
S. cerevisiae cells expressing the TAP-tagged protein were grown at 30 °C and 160 rpm from OD600 of
0.1 to OD600 of 0.5 in one liter of CSM minimal medium (Formedium) supplemented with 10 mg/l uracil,
100 µM 4-thiouracil (4tU) and 2 % glucose. After reaching OD600 of 0.5, another 900 µM 4tU were added
and cells were grown further for 4 h (OD600 of 1.3 till 1.6).
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3.3.2 UV light crosslinking
Following RNA labeling, cells were harvested at 3,000 rpm and 30 °C for 5 min, resuspended in 30 ml
of ice-cold Phosphate-buffered saline (PBS) buffer, and immediately UV-crosslinked. Therefore, living
cells were transferred onto a sterile 15 cm tissue culture plate, irradiated on ice with 365 nm UV light
in a Bio-Link BLX-365 (Vilber Lourmat), applying an energy dose of 10 till 12 J/cm2 and a continuous
shaking at 50 rpm. Subsequently, cells were collected and stuck cells were dislodged by washing plate
with additional 10 ml of PBS buffer. The pooled sample was spun at 3,000 rpm for 3 min and harvested
cells were either directly lysed (as described in Section 3.3.3) or shock-frozen (in liquid nitrogen) and
stored at -80 °C.
3.3.3 Cell lysis and Sonication
Fresh or frozen yeast pellets were resuspended in a total of 4 ml ice-cold Lysis buffer containing pre-mixed
protease inhibitors (1 mM Leupeptin, 2 mM Pepstatin A, 100 mM Phenylmethylsulfonyl fluoride, 280 mM
Benzamidine) and separated into two 2 ml FastPrep tubes. Pre-cooled Zirconia beads (0.5 mm  , al-
ready stored at -20 °C) were added until the tube was filled almost completely and cells were lysed 8
times for 40 sec in the FastPrep-24 with cooling on ice for 2 min in between. Samples were then pooled
into 1.5 ml TPX microtubes and furthermore solubilized for 4 min by sonication using the Bioruptor™
UCD-200 (Diagenode, Inc.) at high intensity and 30 sec on/off intervals. Treated cell lysate was sub-
sequently cleared by centrifugation at 13,000 rpm and 4 °C for 30 min. The upper phase was carefully
collected and used for further steps, i.e. western blotting (Section 3.2) or immunoprecipitation (Section
3.3.4). Alternatively, cell lysate was shock-frozen (in liquid nitrogen) and stored at -80 °C.
3.3.4 Immunoprecipitation
Initially, ten milligram Protein G Dynabeads® [~330 µl] (Invitrogen) were washed twice in 400 µl PBS
buffer. Beads were then incubated with 10 µg rabbit serum IgGs (Sigma) per mg beads in 1 ml PBS
buffer for 45 min at room temperature on a rotating wheel. Unbound antibodies were removed through
trine washing with 1 ml of PBS buffer. Co-immunoprecipitation of tagged proteins to IgG-conjugated
beads was performed on a rotating wheel for 2 h at 4 °C (cold room). Beads were collected in a low-
binding tube for at least 5 min and subsequently washed twice in 400 µl Wash buffer. Beads were
resuspended in 400 µl T1 buffer and stored on ice until proceeding (see Section 3.4).
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3.4 Data acquisition
3.4.1 Partial RNase digest and Phosphorylation
After adding T1 buffer containing 50 U of RNase T1 per ml, the bead suspension was incubated for 20
min at 25 °C and 400 rpm. Beads were then washed twice in T1 buffer and once in Phosphatase reaction
buffer. For dephosphorylation, Antarctic phosphatase reaction buffer (NEB) with 1 U/ml of Antarctic
phosphatase and 1 U/ml of RNase OUT (Invitrogen) were added and the suspension was incubated at
37 °C for 30 min and 800 rpm. Beads were subsequently washed once in Phosphatase wash buffer and
twice in Polynucleotide kinase (PNK) buffer. The phosphorylation reaction was performed in T4 PNK
reaction buffer A (Fermentas) with a final concentration of 1 U/ml T4 PNK and 1 U/ml RNase OUT with
either 1 mM ATP per ml (”cold labeling”) or 0.5 mCi γ-32-P-ATP per ml (”hot labeling”). The reaction mix
was incubated for 30 min at 37 °C and 800 rpm, finally washed four times in 400 µl PNK buffer, and stored
on ice until proceeding (see Section 3.4.2).
3.4.2 On-bead adapter ligation
For 3’ adaptor ligation, beads were resuspended in T4 RNA ligase buffer (NEB) containing 10 U/ml T4
RNA ligase 2 (K227Q) (NEB), 3’ Adaptor [5 mM] (IDT), 1 U/ml RNase OUT (Invitrogen), and 15 % (w/v)
PEG 8000. The bead suspension was incubated for at least 18 h at 16 °C and 400 rpm. Beads were
then washed four times in PNK buffer to remove unligated adapters. For 5’ adaptor ligation, beads were
resuspended in T4 RNA ligase buffer containing 2 U/ml T4 RNA ligase 1 (NEB), 10 mM 5’ Adaptor (IDT),
1mM ATP, 1 U/ml RNase OUT (Invitrogen), 5 % (v/v) DMSO, and 10 % (v/v) PEG 8000. This reaction mix
was incubate for 3.5 h at 16 °C followed by another 30 min at 37 °C. Beads were subsequently washed
twice in PNK buffer and proteinase K buffer.
3.4.3 RNA recovery and Ethanol precipitation
Following adapter ligations, magnetic beads were boiled in 90 µl Proteinase K buffer for 5 min at 95 °C
to eluted the RNA-protein complexes. The buffer was transferred into a low-binding tube and the proce-
dure was repeated. After pooling both, 1.5 mg/ml Proteinase K (NEB) were added and digestion was
performed for 2 h at 55 °C. The released RNA was recovered by acidic phenol/chloroform extraction us-
ing one volume Roti-Aqua Rhenol (Roth) and 1/5 volume chloroform, followed by an overnight ethanol
precipitation at -20 °C, supported by addition of 1 µl GlycoBlue (Invitrogen) and 100 mM of the Reverse
transcription (RT) primer (IDT). Subsequently, precipitated RNA was recovered for 1 h at 15,000 rpm and
4 °C. The RNA pellet was washed in 800 µl of 75 % ethanol and carefully air-dried for approximately 10
till 15 min. Recovered RNA was either stored at - 80 °C (for at least 3 months) or dissolved in a total of
12 µl DNase/ RNase-free dH2O and directly used for First-Strand cDNA Synthesis (Section 3.4.4).
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3.4.4 Reverse transcription
After adding one microliter of 10 mM dNTP mix (Fermentas) to previously precipitated RNA (see Sec-
tion 3.4.3), the sample was heated at 95 °C for 1 min, and then immediately incubated at 50 °C for 5
min. Reverse transcription (RT) was initially performed at 44 °C for 1 h in First-Strand cDNA Synthesis
cocktail (Invitrogen) containing 1x First-Strand Buffer, 5 mM DTT, 2 units/µl RNase OUT, and 10 units/µl
SuperScript® III RTase. Subsequently, the temperature was increased to 55 °C and incubation was pro-
ceeded for another 30 min. The RT reaction was finally stopped by heating at 95 °C for 5 min and samples
were stored on ice or at -20 °C until amplification.
3.5 Barcoded library generation and Sequencing
3.5.1 Fusion PCR
Initial amplification of de-novo transcribed cDNA was performed using the Phusion HF master mix (NEB)
containing 0.2 mM of each dNTP and 20 units/ml phusion polymerase. Illumina-specific adapter input
and barcoding was done using 250 nM of the NEXTflex universal primer in combination with an equimolar
barcode primer (listed in Table 2.8). Applied PCR cycle conditions are listed in the following Table 3.1.
Table 3.1: Cycle conditions for initial cDNA amplification (Fusion PCR)
Step Temperature Time
1 Initial denaturing 98 °C 120 sec
2 Denaturing 98 °C 15 sec
3 Annealing 60 °C 30 sec
4 Elongation 72 °C 25 sec
Repeat steps 2-4 (29 times)
5 Final elongation 72 °C 5 min
6 Hold 10 °C paused
After PCR, amplified cDNA (aDNA) was purified and size-selected on a precast 4% High-ReSolution
agarose E-Gel® (Invitrogen) using a self-made size marker. Amplificates were gel-isolated and purified
applying the QIAquick MinElute Gel Extraction Kit (Qiagen) according to the manufacturer’s instructions.
3.5.2 One-Cycle-PCR
Concatemers and other PCR artifacts in the previously generated aDNA were eliminated through an ad-
ditional PCR cycle, referred to as One-Cycle-PCR. Therefore, the KAPAHiFi™ PCR Kit (Peqlab Biotech-
nologie GmbH) was used containing a final concentration of 0.3 mM dNTP mix, 0.02 units/µl KAPAHiFi™
DNA polymerase, and 200 nM of Nextera primer 1 and 2 in 1x KAPAHiFi™ buffer. For proper ampli-
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fication, 20-40 ng of purified aDNA were used. After denaturing the sample at 94 °C for 200 sec, the
primer annealing was carried out at 55 °C for 30 sec, followed by an extended elongation step at 72 °C
for 240 sec. PCR products were subsequently purified using AMPure XP beads (Beckman Coulter, Inc.)
according to a standard protocol and finally eluted in 10 µl 10 mM Tris-HCl (pH 7.2).
3.5.3 Illumina sequencing
Following quantitation on an Agilent DNA 1000 Chip using a Agilent 2100 Bioanalyzer (Agilent Technolo-
gies, Inc.) according to the manufacturers instructions, cluster generation was performed on Illumina’s
Cluster Station using TruSeq SR Cluster Kit v5-CS-GA containing the Flow Cell v4. Read and index se-
quencing for multiplexed runs was performed using either Illumina’s Genome Analyzer IIx or HiSeq 1500
sequencer. All steps regarding the deep sequencing were done by Stefan Krebs (LAFUGA, Gene Center
Munich); according to the manufacturer’s instructions.
3.6 Global expression profiling
3.6.1 Microarray analysis
Yeast cells were labeled with different concentrations of 4-Thiouracil and subsequently UV-irradiated (as
described in Sections 3.3.1 and 3.3.2). Cells were harvested, resuspended in RiboPure lysis reagents
(Invitrogen), and disrupted by bead beating at 4 °C using silica-zirconia beads (Roth) and the FastPrep-24
(MP). Total RNA was extracted by acid phenol/chloroform extraction using Roti-Phenol (Carl Roth) and
Ethanol precipitated. DNase I treatment was performed using the RiboPure Yeast Kit (Invitrogen). The
concentration and purity of isolated RNAs were determined applying the Experion RNA StdSens Analysis
Kit (Bio-Rad). Target preparation on Affymetrix’ industry-standard, 3’-expression arrays were performed
using the GeneChip 3’ IVT Express Kit (Affymetrix) according to the manufacturer’s instructions.
3.6.2 RNA-Seq for global RNA abundance normalization
Yeast cells were treated as for PAR-CLIP using the identical labeling conditions and a UV-light (365
nm) energy dose of 1 J/cm2 (Sections 3.3.1 and 3.3.2). After bead beating, total RNA was isolated by
acid phenol/chloroform extraction using Roti-Phenol (Carl Roth), and purified and concentrated using
the RNA Clean Concentrator-5 (Zymo Research). Purified RNA was depleted of ribosomal RNAs using
Ribo-Zero rRNA removal kit (Epicenter). The resulting rRNA-depleted RNA was used for multiplexed
RNA-Seq library preparation using the NuGEN Encore Complete RNA-Seq Library Systems. Libraries
were qualified on an Agilent Bioanalyzer 2100 (Agilent Technologies) and sequenced on an Illumina
MiSeq machine.
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3.7 Determination of 4tU-incorporation level
Quantification of the nucleotide composition of total RNA after the labeling with 4-thiouracil using enzy-
matic digestion and HPLC analysis was essentially as described (Andrus and Kuimelis, 2001). Therefore,
50 ml cultures were grown at same conditions as descibed in section 3.3.1. Cells were harvested at 3,000
rpm for 5 min at 4 °C, equilibrated to a comparable amount of cells, and washed with 1 ml of ice-cold PBS
buffer.
3.7.1 Isolation of total RNA
Total RNA was isolated by treating 4tU-labeled cells in 1 ml TRI reagent (Sigma-Aldrich) at 25 °C for 5
min. After adding 200 µl chloroform and approximately 500 µl Zircona beads, the samples were lysed
by milling at 30 Hz and 4 °C for 10 min using the mixer mill MM 400 (Retsch). Samples were then spun
at 15,000 rpm for 15 min, and the aqueous phase, containing the total RNA, was transferred into a new
low-binding tube, already supplemented with 1 µl GlycoBlue (Invitrogen). Precipitation was performed
with 500 µl 2-propanol at 25 °C for 15 min. The RNA was recovered at 15,000 rpm and 4 °C for 30 min.
Pelleted RNA was then washed with 1 ml of 75 % Ethanol (EtOH), air-dried for approximately 10 till 15
min, and subsequently dissolved in 30 µl dH2O at 55 °C for 10 min. RNA was purified and concentrated
using the RNA Clean Concentrator-5 to obtain high quality total RNA (A260/A280 > 1.9, A260/230 > 1.8). The
RNA concentration was finally measured by using the NanoDrop 1000 spectrophotometer.
3.7.2 Enyzmatic ribonucleoside hydrolysis
Twenty microgram of isolated and purified RNA were used for subsequent dephosphorylation and en-
zymatic hydrolysis to single ribonucleosides. For that reason, the RNA was incubated at 37 °C for 18 h
in a 40 l digestion mixture consisting of 18 mM MgCl, 47 mM Tris-HCl (pH 7.5), 0.045 U Snake Venom
Phosphodiesterase (PDE), and 0.23 U Bacterial Alkaline Phosphatase (BAP). Remained RNA fragments
were then twice precipitated at -80 °C for 15 min using 3 M sodium acetate (pH 5.2) and ice-cold abso-
lute ethanol with subsequent spinning at 15,000 rpm and 20 °C for 5 min. The supernantant was then
transfered into a new 1.5 ml tube and evaporated to complete dryness using a SpeedVac (Eppendorf) at
45 °C for approximately 1 h. Dried samples were finally dissolved in 60 µl HPLC buffer A, consisting of 1
% acetonitrile and 50 mM triethylammonium acetate.
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Figure 3.1: Enzymatic reactions of RNA digestion for HPLC analyses. Phosphodiesterase I (PDE) from Crotalus
adamanteus venom catalyzes the exonucleolytic cleavage of phosphodiester bonds in the 3’- to 5’-
direction (marked by red triangel). Resulting nucleoside monophosphates are dephosphorylated by
Bacterial Alkaline Phosphatase (BAP), which finally leads to single nucleosides that are analyzed by
HPLC.
3.7.3 HPLC analysis
Following the enyzmatic hydrolysis, the obtained ribonucleotide mix was separated on a Supelco Discov-
ery C18 reverse phase column with bonded phase silica 5 µM particles (250 x 4.6 mm) connected to the
Programmable Solvent Module 126 (Beckman System Gold). Sample injection (commonly 50 µl) and
detection was done using an Autosampler 507 and Diode Array Detektor Module 168, respectively. Ri-
bonucleotide mix separation was performed applying an isocratic gradient with 90 % Acetonitrile (HPLC
buffer B), a flow rate of 1 ml per minute, and a maximal pressure of 6 kpsi. After each run, the column
was washed in Buffer B for 15 min and finally equilibrated in Buffer A for 5 min.
3.7.4 Calculation of incorporation levels
Determination of integrated areas was done using the software 32 Karat (version 7.0) at 260 nm, 330
nm, and a bandwidth of 5 nm per wavelength. Before calculation of the base composition, each base-
specific integrated area under the curve (AUC) was divided by its appropriate cofactor to get an extinction-
corrected AUC (cAUC). Therefore the molar extinction coefficient (ε) of each nucleoside at a specific
concentration (c) had to be determined for both wavelengths in a 1.2 cm cuvette (= d) (Equation 3.1).
To calculate the cofactor, each ε was normalized by dividing it by the smallest value (Equation 3.2). The
substitution ratio was finally calculated by dividing the cAUC of 4sU by the sum of both the cAUC of rU
and r4sU at 260 nm and 330 nm, respectively.
ε [M−1cm−1] =
E
c [M]×d [cm]
(3.1)
Cofactor =
ε1...4
εmin
(3.2)
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4.1 Sequencing data quality control and mapping
A script for pre-processing of sequencing data obtained from the Illumina GaIIx or Illumina HiSeq ma-
chine was designed and written. The script calls widely used NGS-software and custom scripts with
parameter settings adapted to PAR-CLIP analysis. Initially, adapter sequences are first trimmed from the
raw sequencing files. The quality filter then discards all reads containing unidentified nucleotides (N),
Phreds scores below 30, reads shorter than 15 nt, or reads that are flagged by Illumina’s internal chastity
filter. Quality-trimmed reads are aligned to the S. cerevisiae genome (sacCer3, version 64.1.1) using
the short read aligner Bowtie (version 0.12.7) (Langmead, 2010) with a maximum of one mismatch and
taking unique matches only (options: -q -p 4 -S -sam -nohead -v 1 -e 70 -l 28 -y -a -m 1 -best -strata
-phred33 -quals). The resulting SAM files are then converted into BAM and PileUp files using SAMTools
(Li et al., 2009).
4.2 Calculation of P-values and false discovery rates for factor
binding sites
The P-value calculation was performed for any genomic T site, given the total number of reads covering
the site (”coverage”) and given the fraction of these reads which show the T-to-C mismatch. Owing to the
exquisite sensitivity of the experimental PAR-CLIP procedure, a very stringent P-value cut-off of 0.005
and a minimum coverage threshold of 4 was set.
To estimate the false discovery rate (FDR) at threshold P < 0.005 for each PAR-CLIP experiment, the
number of T sites with T-to-C mismatches among the reads, NT−C, and the number of C sites with C-to-T
transitions among the reads, NC−T , was counted. With the latter, the NFP, the part of NT−C that was not
due to crosslinking, which yielded FDR was estimated (Equation 4.1).
FDR =
NFP
NT −C
(4.1)
4.3 Computation of occupancy profiles
For true cross-linking sites passing our stringent thresholds, the PAR-CLIP-induced T-to-C transitions
strongly dominate over the contributions by sequencing errors and SNPs. Therefore, for any given T
site in the transcriptome, the number of reads showing the T-to-C transition, NTC, is proportional to the
occupancy of the factor on the RNA. But it will also be proportional to the concentration of RNAs covering
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the T site. This concentration was estimated from the RNA-Seq read coverage measured under compa-
rable conditions (3.6.2). To reduce noise, the read coverage NRNA−Seq was estimated by smoothing with
a running mean of window size 30, therefore:
Factor occupancy ∝
NTC
NRNA−seq
(4.2)
The unscaled factor occupancy was then smoothed, again with a running mean over 30 nucleotides.
To fix the scale, a 97 % quantile of occupancy for the called sites (with P-value < 0.005) was set to 100 %.
Hence an occupancy was obtained, relative to the 97 % quantile, but it will be a reasonable estimate for
absolute occupancy under the assumption that the best 3 % of binding sites are nearly fully occupied on
each transcript and that cross-linking efficiency for a given factor does not depend strongly on sequence
context. The latter assumption may be violated in genomic regions depleted of T residues.
4.4 Derivation of precise TSS and pA gene annotations
To annotate TSS and pA sites, the recent TIF-Seq data from (Pelechano et al., 2013) was used which
yielded much sharper sequence features around TSS and pA sites than the previous TSS and pA an-
notation data from (Xu et al., 2009) and also greatly improved the resolution of many PAR-CLIP-derived
occupancy peaks with respect to these features. Therefore, the original S1_TIFs.txt with around 1.8 mil-
lion transcript start and end positions (unique transcript isoforms) was downloaded using only selected
entries with the annotation ”covering one intact ORF”, yielding approximately one million transcripts. For
each gene identifier the most abundant transcript isoform under the YPD condition was picked. Finally,
TSS and pA site were annotated for each gene according to those of the most dominant isoforms, giving
precise TSS and pA positions for 5578 gene transcripts.
4.5 Occupancy profiles for all genes or introns
All transcripts from the filtered TIF-Seq annotation (see above) were sorted by length and aligned at
their TSS. Smoothed occupancies were binned in cells of 20 nucleotide positions times 10 transcripts
to avoid aliasing effects due to limited resolution of the plots. The color code displays the occupancy of
the PAR-CLIPped factor (with the 97 % quantile of these bins scaled to 1). All introns (obtained form
SGD annotation) with lengths between 150 and 600 nucleotides were aligned at the 5’-splice site and the
occupancy of each intron was displayed without binning in either x or y direction.
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4.6 Motif searches with XXmotif results
To find binding motifs for the investigated factors, the 2000 binding sites with the highest occupancies
were selected. Sequence regions ±25 nucleotides around the cross-linked position to XXmotif to de
novo motif discovery were submitted, using parameters ”-negSet -zoops -merge-motif-threshold LOW
-max-match-positions 10”. The negative set submitted to XXmotif was composed of 1000 regions of 51
nt length randomly selected from the yeast transcriptome and carrying no significant binding site.
4.7 Calculation of the ’splicing index’
A selection of 245 verified introns out of the SGD yeast annotation (64.1.1) was used to construct a
sequence file containing exon-intron (EI), intron-exon (IE) and exon-exon (EE) junctions. Pre-processed
sequencing data were mapped to these sequences, and for each of the I = 245 introns, the read counts
at the exact EI, IE and EE junctions (NEI , NIE , NEE , respectively) were used to calculate the log-ratio of
spliced and unspliced mRNA, which was defined here as ’splicing index’ (SI):
SI = log2
2∑Ii=1 NEEi
∑Ii=1(NEIi +NIEi )
(4.3)
4.8 Calculation of the ’processing index’
Read counts Ndown downstream of a pA site can only occur from pre-mRNAs, Ndown = Nprem, whereas
read counts Nup upstream of a pA site are a mixture of mature mRNA counts Nmat and pre-mRNA counts
Nprem. Therefore, Nup = Nmat + Nprem. For increased robustness with regard to different transcript isoforms
and uncertainties in the exact location of pA sites, Nup and Ndown were computed as average of the read
counts within 50 nt upstream and downstream NPM of the pA site over all G gene transcripts, respectively.
The ’processing index’ (PI) was defined as follows:
PI = log2
(
1
G
∑Gi=1 NPMi
∑Gi=1 NMi
)
(4.4)
4.9 Binding profile correlation matrix
For each factor f and all transcripts t between 300 and 5000 nt length, the occupancies in the region
between the TSS and the pA site were rescaled to an equal length of 300 bins. In this way, each transcript
has a resized profile p f ,t , where p f ,t i is the occupancy of factor f at transcript t at location bin i ∈ {1,...,300}.
Next, the mean occupancy per transcript was calculated and assigned each p f ,t to one of 10 equal-sized
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quantiles (deciles). For each of these 10 deciles d the resized profiles p f ,t were summed up to obtain
the whole decile average occupancies which resulted in averaged binding shapes p f ,d i for each factor for
each decile d. For each pair of factors f and f’ and each decile d, the Pearson correlation was computed
between their binding profile shapes p f ,d i and p f
′,d
i as a measure of the similarity of their binding profiles
(Equation 4.5).
cor( f , f ′) =
∑I(p
f ,d
i − p
f ,d
i )(p
f ′,d
i − p
f ′,d
i )√
∑i(p
f ,d
i − p
f ,d
i )
2
√
∑i(p
f ′,d
i − p
f ′,d
i )
2
(4.5)
4.10 Total co-occupancy matrix
To calculate the tendency of pairs of factors to co-occupy similar subsets of transcripts, the pairwise
Pearson correlations of their total occupancies z f ,t over all transcripts t was computed as follows:
cor( f , f ′) =
∑t(z f ,t − z f ,t)(z f
′,t − z f
′,t
i )√
∑t(z f ,t − z
f ,t
i )
2
√
∑t(z f
′,t − z f ′,t)2
(4.6)
Furthermore, noise was reduced by weighting up/ down the contribution of binding sites to the total
occupancy of a transcript that were typical/ atypical of the binding location of the factor within a transcript.
The averaged binding profile p f i of each factor was calculated and from it the normalized weights w f i =
p f i / ∑ip f . These weighted the occupancies along each transcript according to how likely they are to be
functional. The weighted total occupancy z f ,t of a factor f at transcript is therefore computed as follows:
z f ,t =
|p f ,g|
∑
i
p f ,ti w
f
i (4.7)
4.11 Local co-occupancy map
To calculate the tendency of pairs of factors A and B to bind locations in the transcriptome near to each
other, the average occupancy of factor B within ±12 nt of occupancy peaks of factor A (unsmoothed
occupancy data) was computed. To suppress statistical noise, only peaks of A above the 75 % quantile
of all peaks occupancys of A were selected. The average occupancy of B was divided by the background
occupancy of B, which was calculated by averaging the occupancy of B within 25 nt windows out of 2000
randomly selected positions in the transcriptome.
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5.1 A high resolution PAR-CLIP procedure for S. cerevisiae
We used PAR-CLIP to study direct RNA-protein interactions on a global scale at high-resolution (Meth-
ods). For this purpose, we adapted the PAR-CLIP protocol, originally developed by Tom Tuschl and
colleagues (Hafner et al., 2010), to the yeast system as previously described (Creamer et al., 2011; Tuck
and Tollervey, 2013). Briefly, photoactivatable-ribonucleoside-enhanced (PAR)-CLIP relies on an in vivo
incorporation of a photoreactive ribonucleoside analog into nascent RNA transcripts that enhances the
UV light cross-linking efficiency applying a less energetic wavelength of 365 nm (Hafner et al., 2010). Be-
fore the in vivo cross-linking introduces a covalent bond between the protein of interest and the applied
base analogue, it is crucial to incorporate as much as possible of a photoactivatable ribonucleoside into
the nascent RNA without perturbing the cell or changing expression levels. Due to the inability of Sac-
charomyces cerevisiae to incorporate the photoactivatable ribonucleoside 4-thiouridine (4sU) or similar
analogs (6-thioguanosine, 5-iodouridine or 5-bromouridine), the nucleobase analogue 4-thiouracil (4tU)
was used instead (Hafner et al., 2010; Creamer et al., 2011; Sun et al., 2012; Tuck and Tollervey, 2013).
Consequently, several investigations were planned and established to finally get a cutting-edge proto-
col with high resolution. First, we measured the growth changes during 4tU-labeling in S. cerevisiae and
determined resulting in vivo incorporation levels of 4sU by HPLC analysis (Hafner et al., 2010; Andrus
and Kuimelis, 2001). Second, different culture media, a wide variety of base analogue concentrations,
and various labeling periods have been assayed and compared to determine the optimal condition for
subsequent PAR-CLIP experiments in S. cerevisiae. Third, we successfully optimized further crucial
steps including cross-linking efficiency and cell lysis as well as data acquisition.
5.1.1 Labeling efficiency depends on 4tU concentration and labeling time
We measured the maximal absorbance (λ max) of each applied nucleoside and calculated their specific
molar extinction coefficients (Table 5.1). The ribonucleotides Adenosine (rA) and Uridine (rU) as well
as the deoxyribonucleotide Thymidine (dT) had their λ max at around 260 nm, whereas Cytidine (rC) and
Guanosine (rG) showed a shift to 271 nm and 253 nm (UVC), respectively. The base analogue 4sU
absorbed maximally around 345 nm (UVA), but also displayed an absorbance at ~250 nm. Importantly,
an absorbance above 300 nm was only observed for 4sU. Following, the absorbance at 260 nm and
330 nm for each nucleoside was measured and arithmetically averaged using different molar concentra-
tions (10 µM, µ100 M and 1 mM). Individual molar extinction coefficients and resulting cofactors were
subsequently calculated (as described in Section 3.7.4). While rC showed the lowest coefficient for the
common nucleosides, an almost doubled value was assayed for rA, resulting in a cofactor of 1.0 and 1.98
for rC and rA, respectively (Table 5.1). As expected, molar extinction coefficients at 330 nm were only
determined for the base analogue 4sU.
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Table 5.1: Experimentally determined molar extinction coefficients of all applied nucleosides and 4-
thiouridine (4sU) for 260 nm and 330 nm. We measured the molar extinction at three concentrations at
25 °C and neutral pH and calculated the individual coefficients for both wavelengths (Section 3.7.4). The
average error of calculated extinction coefficients was around 7 % under these conditions. Nucleosides
are arranged ascendingly according to their assayed cofactors.
Molar extinction coefficients
Nucloside (analogue) Wavelength (λ max) 260 330 nm Cofactor
Cytidine (rC) 271 nm 7,110 0 1.00
Thymidine (dT) 263 nm 8,520 0 1.20
Uridine (rU) 262 nm 9,055 0 1.27
Guanosine (rG) 253 nm 11,530 0 1.62
Adenosine (rA) 260 nm 14,070 0 1.98
4-thiouridine (4sU) 334 nm 2,410 16,700 2.35
Furthermore, the retention time of each nucleoside (analogue) was determined using an isocratic
gradient on a HPLC reverse phase column (Section 3.7.3). For this purpose, we analyzed a defined
concentration of each substance separately to identify the individual nucleoside-specific retention time
with variances of 0.4–0.8 minutes (Figure 5.1A). The previously investigated cofactors (Table 5.1) were
validated using an equimolar mixture of all common nucleosides. For normalization, we corrected the
integrated areas under the curves (AUC) of each nucleoside via the determined cofactors (AUC→ cAUC).
With this the nucleoside composition was determined to be 20 ± 0.8 % for each nucleoside (Figure 5.1B).
Validation of the entire HPLC procedure including the initial enyzmatic ribonucleoside hydrolysis (Section
3.7.2) was performed by digesting a twenty-four nucleotide long RNA oligonucleotide primer with known
composition (C4G5A7U8). Although each nucleoside was correctly separated in respect to the previously
assayed retention times (Figure 5.1A), the calculated occurrence of rG and rU did not completely agree
with the expected distribution (Table 5.2), which might be due to an incomplete RNA hydrolysis.
Figure 5.1: An equimolar nucleoside mixture enables methode validation. A. Equimolar nucleoside chro-
matogram with measured (red) and corrected extinctions (blue). B. Comparison of uncorrected and
corrected AUCs.
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Table 5.2: Calculation of ribonucleoside composition of a 24-nt RNA oligonucleotide primer (C4G5A7U8) af-
ter RNA digestion and quantitative HPLC analysis. The integrated area under the curve for each
separated ribonucleoside was measured and corrected applying the determined cofactors. The resulting
occurrences (in percent and base counts) are compared to the actual composition.
Nucloside Integrated area Corrected area Occurrence Calculated Actual
Cytidine (rC) 447753 447753 17.4 % 4.18 4
Guanosine (rG) 760241 468804 18.2 % 4.37 5
Adenosine (rA) 1430582 722917 28.0 % 6.72 7
Uridine (rU) 1195693 938860 36.4 % 8.74 8
Based on this findings, we adapted the original protocol from Hafner et al. (2010) to our experimental
conditions and initially measured in vivo incorporation rates after RNA labeling in YPD medium supple-
mented with 4-thiouracil. To achieve this, different concentrations of 4tU were tested and labeling time
were assayed. Resulting incorporation rates are summarized in (Figures 5.2 and 5.4). No significant
incorporation was detected after 6 min labeling using ≤1 mM 4tU (Figure 5.2 and 5.3A). In contrast, 5
mM 4tU, as used for the cDTA approach showed an incorporation level of 0.305 % (Sun et al., 2012).
Within the first 24 min the incorporation rates ranged from 0.097 % (100 µM 4tU) to 0.810 % (5 mM 4tU).
The measured incorporation rate for 100 µM 4tU at 24 min deviated from the series and might be an
analytical error (Figure 5.2). Rates above 1 % were only achieved after 48 min labeling with the high-
est concentration of 4tU (5 mM) and between 96 and 192 min using 500 µM or 1 mM 4tU. The highest
amount of 4sU (with 2.7 %) was measured after labeling with 5 mM 4tU for 192 min (Figure 5.3B). This
led to the conclusion that both, the extended labeling time as well as the final concentration of 4-thiouracil
largely contribute to the labeling efficiency. Nevertheless, the uptake of 4tU as well as the subsequent
incorporation of 4sU into nascent transcripts triggers a nucleolar stress response (Burger et al., 2013).
Consequently, we monitored growth (defects) and global expression levels in subsequent experiments
(see Section 5.1.2).
Figure 5.2: Levels of 4sU incorporation measured by HPLC. Four final concentrations of 4-thiouracil (100 µM,
500 µM, 1 mM and 5 mM) were used for labeling. Six different time points were chosen to measure
4sU incorporation, whereas the labeling time was doubled at each point. The matrix lists the percentage
levels of incorporation, color code indicate by the right.
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Figure 5.3: Chromatograms after HPLC analysis. Common ribonucloesides (rC, rU, rG and rA) were detected at
260 nm (black line). The analogue (4tU/4sU) was measured at 330 nm (red line). Each ribonucloeside
showed a distinct retention time that matched with the run of the ’clean’, equimolar mixture (Figure 5.1A).
Corresponding peaks are labeled; the 4tU (10.2 min) and 4sU (21.1 min) peaks are indicated by an
arrow. A. An almost no detectable 4sU peak was identified after 6 min labeling using 500 µM 4tU, which
led to an incorporation rate around zero as listed in Figure 5.2. B. Highest concentration of 4sU or 4tU
were achieved after labeling with 5 mM for 192 min.
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5.1.2 Labeling conditions influence growth and amounts of cross-link sites
After the addition of 4tU into the YDP, changes in growth during RNA labeling were evaluated by measur-
ing the OD600 at the same time points (6, 12, 24, 48, 96, and 192 min) (Section 5.1.1 and Section 5.1.1).
No growth defects were observed within the first 24 min of labeling, but a reduced growth was monitored
after 48 min (Figure 5.4A). After 192 min the untreated cells had an OD600 of 2.2 ± 0.12, whereas cells
treated with 5 mM 4tU showed a significant growth defect with a final OD600 of 1.5 ± 0.05. The lowest
growth change in relation to the untreated samples was observed for the all samples treated with a final
concentration of 100 µM 4tU. Cells that were incubated with either 0.5 mM or 1 mM 4tU showed a similar
OD600 of ~1.6 after 192 min labeling, suggesting that both concentration disturbing the cell equally.
Figure 5.4: Growth changes during RNA labeling with 4-thiouracil. A. Growth curves show changes in growth
at progressive time points. The green line corresponds to the untreated samples, whereas the red line
stands for the highest concentration of the base analogue 4tU (with 5 mM). B. Growth curves compare
cultures incubated with a total of 1 mM 4tU in either YPD medium or Synthetic complete (SC) medium
supplemented with 10 mg/l uracil (50 %) and 100 µM 4-thiouracil.
Initially, 4tU-labeling was performed in YPD medium that commonly consists of 2 % peptone and 1 %
yeast extract (Table 2.4). The exact composition of both components is mainly manufacturer-dependent
and most variable. Due to this undefined character, an alternative culture medium for 4tU labeling was
tested. For this purpose, we chose Synthetic complete (SC) medium containing a complete supplement
mixture of amino acids and vitamins (Formedium). We supplemented the SC medium with 100 µM 4-
thiouracil, 2 % glucose, and only 10 mg/l uracil (50 % of the original amount). The defined character of
SC as well as the reduction of uracil was intended to increase the 4tU uptake and 4sU incorporation.
For this purpose, we changes the labeling strategy by incubating cells from OD600 of 0.1 to 0.5 in SC
before then the concentration was raised to 1 mM 4tU by adding another 900 µM. Surprisingly, no obvious
distinctions in growth were observed between YPD and SC medium (Figure 5.4B). Due to this finding,
we again measured incorporation levels after performing the 4tU-labeling in SC medium (as previously
described).
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Even though assayed incorporation levels in SC medium were only slightly higher in comparison to
YPD (Figure 5.5A), the amount of high-resolution cross-link sites was remarkably increased in SC using
the identical dose of UV light (Figure 5.5B–D).
1.0
0.8
0.6
0.4
0.2
   0
1 mM for 4 h in YPD 1 mM for 4 h in SC
5 10 20 50 100 200 5 10 20 50 100 200
B
Reads (N)
T
ra
n
s
it
io
n
s
 a
t 
p
o
s
it
io
n
 (
k
) 
/ 
R
e
d
a
s
 (
N
)A 4
3
2
1
   0
In
c
o
rp
o
ra
ti
o
n
 r
a
te
 (
%
) 
  
 a
ft
e
r 
4
 h
 l
a
b
e
lin
g
 
   0.5    1.0    5.0
4tU concentration (mM)
YPD
SC
P
o
s
it
io
n
s
 w
it
h
 t
ra
n
s
it
io
n
s
 (
x
1
0
  
)
A/C A/G A/T C/A C/G C/T G/A G/C G/T T/A T/C T/G
280
0
3
C
A/C A/G A/T C/A C/G C/T G/A G/C G/T T/A T/C T/G
Possible transition Possible transition
1 mM for 4 h in SC 1 mM for 4 h in SC
D
PAR-CLIP-specific T-to-C transition*
*
140
70
210
0.2
0.1
0
P
ro
b
a
b
ili
ty
Figure 5.5: Incorporation quality is increased by defined Synthetic complete (SC) medium using the example
of Nrd1. A. Comparison of incorporations rates after 4tU treatment in both YPD and SC medium using
three different concentrations (500 µM, 1 mM, and 5 mM). B. Discrete probability distribution of correct
cross-link sites (blue dots) after labeling in YPD (left) and SC medium (right) compared to other possible
transitions resulting from undefined events like UV light damage (orange dots). C. Counts of all possible
base transitions and their corresponding nucleotide distribution probabilities (D).
5.1.3 Cross-linking efficiency depends on UV light dose
Another critical step in the PAR-CLIP procedure is the in vivo UV light cross-linking at 365 nm. Compared
to related approaches like individual-nucleotide resolution CLIP (referred to as iCLIP) (Knig et al., 2010),
decreasing the wavelength to 365 nm has three main advantages in relation to 254 nm (iCLIP): (i) less
UV damage using the same amount of radiation energy (Ascano et al., 2012), (ii) an improved RNA
recovery up to 1000-fold applying a photoactivatable nucleosides (Hafner et al., 2010), and (iii) high-
resolution binding sites due to PAR-CLIP-specific T-to-C transition, which results from the incorporated
base analogue (Hafner et al., 2010; Spitzer et al., 2014). Even though it is known that the radiation energy
of 254 nm does not break phosphodiester bonds, it is believed that UV254 might disrupt the disulfide bond,
which is established during UV cross-linking (Correia et al., 2012).
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To ensure a maximal cross-linking efficiency, several doses of UV light at 365 nm were tested after 2 h
labeling using 1 mM 4tU. The tested protein (Nrd1-TAP) was immunoprecipitated and cross-linked RNAs
were labeled radioactively using γ-32-P-ATP, and subsequently analyzed via SDS-PAGE (as described in
Section 3.4.1). Instead of a sharp radiating band, a smear displaying the protein of interest with different
sizes of covalently bound RNA transcripts was observed. Knowing the molecular weight of the analyzed
TAP-tagged protein as well as the mean weight of a RNA nucleotide (0.32 kDa), the size distribution of
bound fragments before the RNase treatment could be calculated.
The lowest radiation signal was observed after UV cross-linking using 0.5 J/cm2, whereas the signal
intensities accumulated with increasing energy doses (Figure 5.6A). In contrast, less than 0.5 J/cm2 are
needed to obtain adequate cross-links in human cell lines (Hafner et al., 2010; Farazi et al., 2014).
Therefore, clear differences between yeast and thin-layered cell lines were demonstrated. This can be
explained by the thick cell wall, the spherical shape, and the non-adherent growth of yeast cells, which
all together leads to an increased absorption of UV light. In order to determine cell viability after cross-
linking, UV light treated cell were again incubated in YPD. Strong growth defects compared to untreated
cells were observed after cross-linking with energy dose above 1 J/cm2 (Figure 5.6B). Similar results
were obtained for ChIP experiments after cross-linking for 20 min at 20°C using 1 % formaldehyde (data
not shown).
Figure 5.6: Cross-linking efficiency depends on UV365 light dose. Four different doses were tested: 0.5, 1, 5 and
10 J/cm2. Depicted are the effects of increased UV light exposure using the example of Nrd1-TAP (size:
~85 kDa). A. The autoradiogram of a SDS-PAGE gel exemplifies the enhanced yield of cross-linked,
radioactively labeled RNA (top). Same gel after coomassie staining (below). B. Viability decreases
during the UV light treatment and results in dysfunctional or not viable cells after the in vivo cross-linking
(XL).
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5.1.4 Yeast cells require harsher lysis approaches than mammalian cells
While mammalian cell lines can be easily lyzed by the addition of a sufficient amount of detergents
(NP-40, Triton X-100, etc.), yeast cells require a more robust, physical treatment. Consequently, we
optimized the cell lysis by testing different approaches. Achieved lysis efficiencies were determined
photometrically (OD800) and by light microscopy. Firstly, we tested different lysis buffers containing various
concentrations of Triton X-100, SDS and/ or NP-40. Because we observed poor lysis effects, we tried to
transform cells into spheroplasts before the detergent-based treatment. For this purpose, we assayed
three different enzymes with lytic activity against living yeast cell walls. Each enzyme was tested at 37°C
with a final concentration of 50 U per ml cell suspension. No spheroplast formation was observed after
the treatment with Glusulase, a commercial preparation containing both the β -glucuronidase as well as
sulfatase (Figure 5.7A). After the incubation with Lyticase, nearly 20 % of cells had lost their cell wall.
However, highest rates of spheroplast formation with almost 70 % effected cells was obtained after the
treatment with Zymolyase (Figure 5.7B).
Figure 5.7: Cell lysis efficiency after enzymatic and mechanical treatment. A. Progress of spheroplast forma-
tion using three different lytic active enzymes preparations (50 U/ ml cell suspension) was measured
at OD800. Reactions were performed at 25 and 37 °C, and subsequently averaged. B. Comparison of
untreated and Zymolyase-treated cells (after 60 min). Intact, cell wall-containing cells are darker, while
spheroplasts appear more transparent. The arrow indicates an already cracked spheroplast. C. Micro-
scopies of mechanical lyzed yeast cells after using the advanced FastPrep-24 homogenizer for two, four
and eight runs of 40 sec each. Disrupted cells are arrow-marked, while unlyzed and intact cells are
highlighted in red.
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Despite these results, we were not able to immunoprecipitate the proteins of interest from cells that
have been treated with either Lyticase or Zymolyase anymore. This might be either a result of the ex-
tended incubation at 37°C, which results in stress-induced expression changes, or due to ’polluted’ en-
zyme stocks containing several unknown ingredients (i.e. various proteases). No information concerning
additional ingredients was supplied by the manufacturer.
Finally, we tested three mechanical approaches that have been proven to effectively disrupt cells. By
using the high-pressure french press system TS 0.75 (Constant Systems Ltd.), a lysis efficiency of ~80 %
was achieved after the first 5 min. Despite the excellent lysis properties this device was finally impractical
due to extreme frothing effects and a loss of material of about 30 %. In case of the two-dimensional mixer
mill MM 400 (Retsch GmbH), comparable results were obtained after at least 90 min of milling. Even
in the cold room, samples had to be additionally cooled down every 15 min to avoid thermal overheat-
ing. Consequently, we were looking for a variant with comparable lysis capabilities without sample loss
and denaturation effects. An appropriate device was finally found in the FastPrep-24 homogenizer (MP
Biomedicals) that led to a lysis efficiency of ≥80 % within eight runs of 40 sec each (Figure 5.7C).
5.1.5 Improper RNase treatment impairs cDNA library preparation
In order to ensure an optimal fragment size for subsequent adapter ligation, we assayed the RNA frag-
mention by RNase T1 digestion. Initially, we applied the same RNase T1 concentration as used by
Hafner et al. (2010) for the first digestion reaction. Treated RNA segments were radioactively labeled
using γ-32-P-ATP (as described in Section 3.4.1), and the immunoprecipitated protein (Nrd1-TAP) with
bound and labeled transcripts was separated by SDS-PAGE. In comparison to untreated fragments (Fig-
ure 5.8A, left lane), the RNase-digested samples already displayed strong degradation effects, even
without a subsequent RNase treatment (Figure 5.8A, right lane). Hafner et al. (2010) used two RNase
treatments to reach an adequate fragment size, whereas the initial digestion is firstly applied to pre-digest
bound transcripts. Due to the observed effects of the first treatment, we decided to abolish this step and
searched for alternatives. Because sonication is commonly used for DNA fragmentation during ChIP-
chip experiments (Mayer et al., 2010) (Figure 5.8B, upper gel), we assayed the shearing effects of the
acoustic cavitation on total RNA size applying Diagenode’s Bioruptor ultrasonicator. Even though small
RNAs seemed to be resistant to the ultrasonic treatment (Figure 5.8B, lower gel), rRNAs showed clear
fragmentation effects with increasing sonication cycles (Figure 5.8B, middle gel). To avoid RNA and pro-
tein damage by the acoustic cavitation, we finally chose 4 cycles of sonication and substituted the initial
RNase digestion by this mechanical lysis approach. Pre-fragmented RNA transcripts were subsequently
RNase-treated as performed in the original PAR-CLIP protocol. Due to the general overexpression of
proteins in mammalian cell lines (Hafner et al., 2010; Spitzer et al., 2014; Farazi et al., 2014), the yield
of cross-linked binding partners seems to be highly increased and therefore enhances the separation of
RNA segments bound by the protein of interest. While Hafner et al. (2010) added RNase T1 to a final
concentration of 100 U/µ l, we deemed an 2,000-fold reduction (50 U/ml) appropriate. This tremendous
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reduction might be explained by the decreased amount of immoprecipitated protein resulting from our not
overexpressed approach. Nevertheless, the combination of both the sonication (4 cycles) and optimized
RNase treatment (50 U/ml for 20 min at 25°C), led to an averaged Gaussian-like fragment size distribu-
tion around 40 nucleotides (Figure 5.9C), perfectly suitable for an Illumina sequencing platform (GAIIx,
MiSeq or HiSeq).
Figure 5.8: Sonication of cross-linked RNA to ensure fragmentation is more controllable than the initial
RNase digestion. A. The first and initial RNase T1 treatment from the original PAR-CLIP protocol
(Hafner et al., 2010) digests cross-linked RNA most intensively and disables the following cDNA library
preparation. Autoradiogram of immunoprecipitated Nrd1-TAP samples, run on a SDS-PAGE, shows size
of cross-linked RNA after 1 h IP in lysis buffer with (+) or without (-) RNase T1 (1 U/µ l). B. Shearing
effects of sonification on different classes of RNAs. Diagenode’s Bioruptor ultrasonicator was used to
shear total RNA using 10, 20 and 30 cycles of sonication at high intensity and 30 sec on/off intervals.
Different classes of RNAs were isolated separately and run on a high-resolution 18%-Urea-PAGE gel:
mRNAs (top), rRNAs (middle), and small RNAs (bottom).
5.1.6 Optimized library preparation improves data outcome
After we ensured a proper fragment size of bound transcripts (previous Section 5.1.5), a new protocol for
data acquisition in order to improve both the quantity and quality of cDNA libraries had to be established
and optimized. In the original PAR-CLIP protocol from Hafner et al. (2010), adapter ligation and size
selection are performed by applying multiple radioactive labeling procedures and subsequent gel purifi-
cations (Hafner et al., 2008). We applied this protocol intensively, but were not able to produce a single,
’sequenceable’ cDNA library. This might have two explanations: (i) we were not able to recover enough
RNA segments due to the limited amount of proteins (as discussed before), and/ or (ii) we lost too much
material during the two ligation and purification steps.
The original protocol for cDNA library preparation from Hafner et al. (2008) is an enormous and quite
sophisticated procedure using a multitude of radioactive material. Due to this fact, we searched for a com-
mercial ”all-in-one package” for RNA library preparation that contains all required enzymes, buffers, and
oligonucleotide primer. An adequate product containing even the specialized pre-adenylated 3’ adapter,
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was finally found in the NEXTflex Small RNA Sequencing Kit v1 (Bioo Scientific). This complex and ex-
pensive oligonucleotide modification was introduced to prevent ligation to the blocked 5’ adaptor by using
a truncated RNA ligase. However, we observed a strongly increased adapter dimer formation resulting in
a DNA band at 118 bp (Figure 5.9A, left lane). After extraction and sequencing of the actual library above
that size (~130 till 160 bp), roughly 40 % of sequenced reads still contained only adapter sequences. We
assumed that especially the modified ligation adaptors might have been defective in terms of integrity
and/ or purity, which consequently leads to unwanted ligations and a dramatically reduced data outcome.
Finally, the entire library preparation procedure was renewed and intensively optimized. To circumvent
adapter dimer formation, the ligation protocol was modified and converted to a so called ”on-bead liga-
tion” procedure (Methods). In comparison to successive ligations that are separately performed in the
same reaction tube and/ or buffer conditions, here referred to as ”mixed ligation”, the varying buffers and
enzymes, as well as oligonucleotides are removed much more efficiently. As a consequence, no PCR
product pointing out an adapter dimer was obtained following the on-bead ligation and associated wash-
ing steps (5.9A, right lane). We additionally validated the tremendous improvement with the BioAnalyzer
by comparing both libraries obtained from either mixed or on-bead ligation (Figure 5.9B). While the mixed
ligation of the NEXTflex kit resulted in a pervasive dimer peak at ~118 bp, the library obtained from the
on-bead ligation showed a clear distribution between 120 and 220 bp with a maximum at ~160 bp and,
lacked the dimer band (Figure 5.9B).
Figure 5.9: Optimized data acquisition improves library size and yield. A. Nrd1-TAP cDNA library using a com-
mercial preparation kit (left) and an optimized protocol (right). B. On-bead ligation minimizes adapter
dimer formation. C. Averaged fragment sizes after adapter-trimming provide an insight into size distribu-
tion of previously bound RNA fragment.
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Importantly, not only the size of the final library (after the adapter-trimming) was optimized (Fig-
ure 5.9C), we also noticed a multiple increased yield that might be due to an approximately 6-fold re-
duction in terms of the adapter formation (Figure 5.9B). These changes and optimizations finally ensured
an increased number of specific, information-containing reads, and therefore improved and facilitated the
data outcome and further data analyses, respectively.
5.2 An advanced computational pipeline for PAR-CLIP data
We designed a processing pipeline for sequencing data obtained from PAR-CLIP experiments, which
have been sequenced on either an Illumina GAIIx or HiSeq machine. For this purpose, we combined open
source tools with mainly self-written R and python scripts and termed our pipeline ’CLiPAR’ (Figure 5.10).
The programming and modulation of the pipeline was predominantly performed by Phillipp Torkler and
Alexander Graf. Used parameter settings for the pre-processing pipeline, including the quality trimming
and mapping (Figure 5.10), have been individually adapted to our PAR-CLIP procedure to finally ensure
the highest possible accuracy. First we removed remaining adapter sequences that have already become
≤5 % due to the optimized library preparation (as previously discussed).
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Figure 5.10: Schematic overview of the CLiPAR pipeline. Raw data was obtained from an Illumina platform
(GAxII or HiSeq). The pre-processing block contains several moduls (orange) used for demultiplex-
ing, adapter trimming, quality-filtering, mapping and format conversion. The tool ”FastQC” (purple)
was applied for initial data evaluation. Following pre-processing the actual modeling (blue) and post-
processing (red) took place. For motif discovery the external tool ”XX motif” was used (Hartmann et al.,
2013) (yellow). Required data input like the reference genome or the annotations are coloured green.
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To characterize the quality of our sequenced reads, we determined the Phred quality score by base
calling each nucleotide. Surprisingly, most data sets had already a very high accuracy by predominantly
showing mean sequence qualities above 20 (Figure 5.11A), corresponding to a base call accuracy of 99
%. Due to the excellent data quality of the performed PAR-CLIP experiments, we were finally able to
set the quality filter threshold to 30, meaning a minimal probability of one incorrect base call within 1000
nucleotides (= 99.9 % accuracy) (Figure 5.11B).
Figure 5.11: Phred scores enable validation of data quality. (A.) Averaged Quality score distributions over all
sequenced reads. (B.) Phred scores across all bases after quality filtering using the ’CLiPAR’ pre-
processing pipeline.
Quality-trimmed reads were then mapped to the S. cerevisiae genome using the short read aligner
Bowtie (Langmead, 2010) with PAR-CLIP-adapted parameters (see Section 4.1). Chemical cross-links
between the PAR-CLIPped protein and the RNA-incorporated 4tU lead to U-to-C transitions during
reverse transcription that, when mapped to the genome, manifest themselves as T-to-C mismatches
(Hafner et al., 2010). However, other possible sources of nucleotide mismatches are sequencing errors
and differences between the genome sequence of the organisms used in PAR-CLIP experiments and
the reference sequence onto which the PAR-CLIP reads are mapped. To calculate P-values for true
cross-linking sites, a null hypothesis had to quantitatively modeled, i.e. the probability that the T-to-C mis-
matches observed in reads covering a certain T nucleotide in the genome are not caused by cross-links
between the immunoprecipitated factor and the RNA, but are due to the other sources of mismatches.
This null model distribution could finally be estimated by fitting a two-component binomial mixture distri-
bution to the frequency of the other 11 possible mutations (as previously shown, Figure 5.5D). The first
binomial component models the sequencing errors, while the second component models SNPs (Meth-
ods). Luckily, the cross-linking sites that passed our very stringent thresholds strongly dominated over the
contributions by sequencing errors and SNPs, and were assessed being ’true’ induced T-to-C transitions
resulted from the performed PAR-CLIP experiment. A rough overview of the CLiPAR pipeline is given in
Figure 5.10, depicting the main process flow with its modules.
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Before occupancy profiles and correlations for all genes or introns could be computed, most precise
annotations for transcriptions start sites (TSS), splice sites (SS) and polyadenylation sites (pA) had to be
used. Initially, we applied the TSS and pA annotations obtained from tiling array analyses by Xu et al.
(2009) (Figure 5.12A). Even though these annotations already provided high-resolution data and deep
insights, we were still able to greatly improve the resolution of many PAR-CLIP-derived occupancies by
using the recent annotations derived from transcript isoform sequencing (TIF-Seq) (Pelechano et al.,
2013). Because RNA-Seq and its variants demonstrate a much broader dynamic range compared to
micro and tilling arrays, a more precise detection of low abundance transcripts or their isoforms, as well
as the identification of genetic variants in a single-nucleotide resolution can be accomplished as used
for various CLIP experiments (Ule et al., 2003; Hafner et al., 2010; Pelechano et al., 2013; Tuck and
Tollervey, 2013; Spitzer et al., 2014). We finally picked the most abundant transcript isoform (Section
4.4), giving precise TSS and pA positions for 5578 gene transcripts, and were consequently be able to
see much sharper sequence features around both the TSS and pA sites (Figure 5.12B).
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Through CLiPAR, we were now able to analyze our PAR-CLIP data in high-resolution and in a much
more individualized and comprehensible way in comparison to other, already published computational
approaches for PAR-CLIP analyses like CLIPZ, PARalyzer, wavClusteR and miRTarCLIP, etc. (Khorshid
et al., 2011; Corcoran et al., 2011; Sievers et al., 2012; Chou et al., 2013). Whereas the CLIPZ server
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(at the Swiss Institute of Bioinformatics) comes with a graphical user interface (GUI) (Khorshid et al.,
2011), most available tools still require advanced knowledge in bioinformatics, especially in the statistical
computing environment R as well as in Bioconductor or the Comprehensive R Archive Network (CRAN)
packages. To solve this issue, we additionally wrote wrapper to include our pipeline into Galaxy, an
open, web-based platform with an user-friendly GUI (Goecks et al., 2010). Thus, it can be ensured
that even user with less bioinformatical background are able to use our pipeline up to a certain point.
However, all introduced computational approaches have their limitations and do not offer an overall
solution. While the wavClusteR package for instance require an already mapped and pre-processed
input file, generated by SAMTools (Li et al., 2009; Sievers et al., 2012), the entire analysis pipeline of
miRTarCLIPs is limited to microRNA target site detection (Chou et al., 2013). A recently tailored analysis
tool, dubbed as PARalyzer, firstly includes an interaction site identification by using a novel motif-finding
algorithm (Georgiev et al., 2010; Corcoran et al., 2011). Compared to our pipeline, PARalyzer still requires
further efforts and computational skills to pre- and even post-process the issued data individually. As an
important issue of bioinformatic tools remains the accessibility of the source code(s). The CLIPZ pipeline
for instance mainly remains unknown and confirms its actual ”blackbox” character. We addressed this
issue by offering two possibilities (Figure 5.13): (i) a default variant using PAR-CLIP-specific settings or
(ii) the ability to manually change each value individually.
Figure 5.13: Screenshot of CLiPAR, integrated into Galaxy’s graphical user interface. Depicted are the main
menu with ’Default’ settings (left) and the after choosing the ’Full parameter list’ of the initial ’PAR-CLIP
settings’ (right).
Even though we did not solve every problem, we could at least present a transparent and powerful
tool for analyses of sequencing data obtained from PAR-CLIP experiments (Torkler et al., in preparation).
With the development and usage of our new, cutting-edge computational pipeline, both the quantity and
the quality of the data outcome was dramatically improved, as it will be demonstrated in Section 5.3.
66
5 Results and Discussion
5.3 Transcriptome maps of mRNP biogenesis factors define
pre-mRNA recognition
To map mRNP biogenesis factors over cellular RNA at high resolution, we optimized the PAR-CLIP pro-
tocol and obtained high RNA labeling efficiencies with 4-thiouracile (4tU) in exponentially growing yeast
cells (Methods). We found conditions that led to high reproducibility between biological replicates (Fig-
ure 5.14A) and enabled high 4tU incorporation levels of ~2 % (Andrus and Kuimelis, 2001) without signif-
icant changes in cellular mRNA abundance (Figure 5.14B and 5.16A).
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Figure 5.14: 4tU labeling and UV-treatment leave gene expression levels nearly unchanged. A. Correlation
of expression levels of between pairs of biological replicates with same treatment: without 4tU label-
ing after 4tU-labeling, and after subsequent UV-light treatment with an energy dose of 1 J/cm2. B.
Correlation of expression levels between cells after the various treatment steps during the PAR-CLIP
procedure.
We also developed a computational pipeline for data analysis that uses a statistical model to com-
pute P-values for factor binding sites (Section 5.2 and Figure 5.10). The pipeline also analyzes the
cross-linked region with the motif discovery tool XXmotif (Hartmann et al., 2013) and detects short motif
preferences. For each factor, we found between 25,000 and 800,000 high-confidence protein-RNA bind-
ing sites with a P-value below 5×10−3, which corresponds to low false discovery rates of 0.18–3.5 %
(Table 5.3, Methods). We applied the optimized PAR-CLIP protocol to 23 mRNP biogenesis factors that
showed reproducible signals (Table 5.3).
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Table 5.3: mRNP biogenesis factors analyzed by PAR-CLIP in this work [RRM = RNA recognition motif; ZF =
zinc finger domain].
Biogenesis
event
Factor/
subunit
Complex RNA-binding
domain
PAR-CLIP
XL sites
False discovery
rate [%]
Capping Cbc2 CBC RRM 98,034 0.178
Splicing Luc7 U1 snRNP ZF 93,261 1.035
Mud1 U1 snRNP RRM 99,384 1.918
Nam8 U1 snRNP RRM 151,813 1.675
Snp1 U1 snRNP RRM 25,493 0.447
Ist3 U2 snRNP RRM 66,003 3.184
Mud2 BBP-U2AF65 RRM 801,430 1.769
Msl5 BBP-U2AF65 ZN 476,370 1.961
3’-Processing Rna15 CFIA RRM 582,756 3.463
Mpe1 CPF ZF 122,500 2.262
Yth1 CPF (PFI) ZF 59,049 3.432
Cft2 CPF (CFII) - 189,866 1.723
Pab1 - RRM 233,513 2.052
Pub1 - RRM 371,902 1.332
Export Hpr1 THO/TREX - 249,887 1.913
Tho2 THO/TREX - 400,965 1.064
Sub2 TREX - 228,620 1.085
Mex67 TREX - 288,579 1.010
Yra1 Export adaptor RRM 400,156 0.681
Nab2 Export adaptor ZF 283,606 2.413
Npl3 Export adaptor RRM 770,240 1.282
Hrb1 SR-like RRM 395,402 0.976
Gbp2 SR-like RRM 65,692 0.182
These include the cap-binding complex (CBC) subunit Cbc2 and components of the splicing machinery,
namely the yeast homologs of the branch point (BP)-binding protein BBP (Msl5) and U2AF65 (Mud2),
and subunits of the snRNPs U1 (Luc7, Mud1, Nam8/Mud15, Snp1) and U2 (Ist3/Snu17). Factors in
the 3’-processing machinery included the Rna15 subunit of cleavage factor (CF) IA, and three subunits
of the cleavage and polyadenylation factor (CPF), Mpe1, Yth1 (CPF subcomplex PFI), and Cft2/Ydh1
(CPF subcomplex CFII). We also included nine proteins implicated in mRNP export, namely subunits of
the THO/TREX complex (Hpr1, Tho2, Sub2), the export factor Mex67, and its putative mRNA adaptors
Nab2, Npl3 (also known as Nop3 or Nab1), and Yra1/She11, and the SR-like factors Gbp2 and Hrb1.
Finally, we studied the poly(A)- and poly(U)-binding proteins Pab1 and Pub1 that regulate mRNP export
and stability (Mangus et al., 2003). Together these data map the protein-RNA interaction landscape
underlying mRNP biogenesis (Figure 5.15 and Supplementary Figure S1).
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Figure 5.15: Transcript-averaged occupancy profiles of mRNP biogenesis factors. Individual ORF-Ts were
scaled such that their TSSs and pA sites coincide.
5.3.1 RNA abundance normalization reveals capped transcripts
PAR-CLIP cross-links for the CBC subunit Cbc2 clustered at the 5’-ends of mRNAs as expected, but often
extended for several hundred nucleotides (nt) downstream (Figure 5.16C). We found however that Cbc2
binding appeared much more focused at mRNA 5’-ends after the data were corrected for RNA abundance
(Figure 5.16D) measured by RNA-Seq under the same experimental conditions (Figure 5.16B). We esti-
mated relative occupancies of the cross-linked factors along mRNAs by dividing the frequency of T-to-C
transitions by the RNA-Seq signal at this site (Methods). The normalization reduced the transcript-to-
transcript signal fluctuation, led to an even distribution of estimated occupancy over RNAs with different
abundance (Figure 5.16E), and abolished a weak artificial correlation of PAR-CLIP signals with RNA lev-
els (Figure 5.16F). The resulting distribution of transcript-averaged occupancy profiles was very similar
between strongly and weakly bound transcripts (Figures 5.16 and 5.17).
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Figure 5.16: PAR-CLIP measurements with RNA abundance normalization estimate factor occupancies over
the yeast transcriptome. A. 4-thiouracil (4tU) labeling has only a very minor effect on cellular mRNA
levels. Vulcano plots of expression fold changes for mRNAs measured by Affymetrix microarrays show
that only few mRNAs significantly change their abundance due to RNA labeling, incubation on ice, and
UV light exposure. B. Smoothed Cbc2 RNA-Seq data in sense (blue) and antisense (green) direction
for all open reading frame-containing transcribed regions (ORF-Ts). ORF-Ts are sorted by length and
aligned at their transcription start site (TSS). C. Smoothed, raw Cbc2 RNA-binding strength as mea-
sured by the number of PAR-CLIP T-to-C transitions per U site in sense (blue) and antisense (green)
direction for all ORF-Ts sorted by length and aligned at their TSS. D. Normalization of PAR-CLIP sig-
nals reduces noise. Cbc2 occupancy as estimated by dividing the number of T-to-C transitions for each
U site by the RNA-Seq signal at the corresponding genomic position in sense (blue) and antisense
(green) direction for all ORF-Ts. E. Normalization of PAR-CLIP signals enables interpretation as oc-
cupancy profiles. Whereas raw PAR-CLIP binding strength (shown in C) strongly depends on mRNA
level, normalized occupancies (shown in D) are independent of mRNA levels. Y-axis: percentage of
transcripts whose mean occupancy within the first 90 nt of a transcript is larger than the average of
this mean over all ORF-Ts. F. Normalization abolishes the dependence of estimated occupancy on
mRNA level. Pearson correlation between mRNA level and the PAR-CLIP binding strength in the first
90 nt of each ORF-T before (top) and after (bottom) RNA abundance normalization. G. Cbc2-binding
profiles are independent of factor occupancy. Transcript-averaged Cbc2 occupancy for three mRNA
level classes [100–90 %, 70–60 %, and 40–30 % expression quantile].
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Figure 5.17: Occupancy profiles are independent of factor occupancy. Transcript-averaged occupancy for three
expression level classes [100–90 %, 70–60 %, and 40–30 % expression quantile] of Mud2, Rna15, and
Yra1. This demonstrates that occupancy profiles are reliable even at lowly occupied genes.
The normalization thus leads to realistic profiles and prevents misinterpretation due to systematic over-
representation of abundant transcripts. In the normalized data, strongest binding of Cbc2 was observed
within the first ~90 nt downstream of the transcription start site (TSS) within the 5’-untranslated region
(5’-UTR) of mRNAs (Figures 5.15 to 5.17). The normalization also enhanced Cbc2 signals on ncRNA
transcripts (Figure 5.16C–D, green panels), facilitating the detection of capped ncRNAs (Figure 5.17 and
Supplementary Figure S1). Widespread Cbc2 binding was observed at the 5’-end of divergent ncRNA
transcripts that emerged from bidirectional promoters antisense to mRNAs. Cbc2 sites were found start-
ing at ~120 nt upstream of the TSS of the sense transcript, with the peak of Cbc2 cross-linking at ~250
nt (Figure 5.18, upper panel). This is consistent with the presence of two distinct Pol II initiation com-
plexes for sense and divergent transcription from bidirectional promoters (Rhee and Pugh, 2012), and
indicates that divergent transcripts are capped before they associate with the Nrd1 complex that triggers
their degradation (Jensen et al., 2013; Mischo and Proudfoot, 2013; Schulz et al., 2013). Cbc2 also
cross-linked to antisense RNA 100–300 nt upstream of the polyadenylation (pA) site, identifying capped
antisense ncRNAs at the 3’-ends of many genes (Figure 5.18, lower panel).
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We also identified Cbc2-binding sites in cryptic unstable transcripts (CUTs) and stable untranslated
transcripts (SUTs) (Wery et al., 2011), with stronger signals for CUTs (Figure 5.19A–B). The Cbc2 data
also enabled comparison with the recent CRAC-based mapping of Cbc1, the other subunit of CBC (Tuck
and Tollervey, 2013). Both Cbc1 and Cbc2 showed RNA interactions at the 5’-ends of transcripts, cross-
validating the studies. However, the PAR-CLIP protocol and normalization procedure used here appar-
ently led to more focused signals at RNA 5’-ends and enhanced signals for short-lived RNAs and RNAs
with low abundance, prompting us to use it for an investigation of factors involved in the recognition of
pre-mRNA elements.
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5.3.2 Conserved recognition of pre-mRNA introns
Intron recognition is the initial step in pre-mRNA splicing and was extensively studied in vitro (Will and
Lhrmann, 2011). It begins with binding of BBP to the branch point (BP) and binding of U2AF65 to a
pyrimidine-rich region between the BP and 3’-splice site (3’-SS), and continues with binding of the U1
snRNP to the 5’-SS. The resulting complex E (Figure 5.20) is then remodeled, and U2 snRNA displaces
BBP by base pairing with the BP region, positioning U2 snRNP near the 3’-SS and giving rise to complex A
(Figure 5.20).
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Figure 5.20: Model of factors recognizing an intron during formation of E and A complexes.
The protein-RNA interactions underlying intron recognition have not been systematically analyzed in
vivo. Despite the rapid degradation of introns in vivo, our protocol could capture intron sequences bound
by splicing factors involved in intron recognition (Figures 5.21A-B and 5.22). Cross-linking signals for
the BBP homologue Msl5 and the U2AF65 homologue Mud2 spanned entire introns and showed peaks
near the 5’-SS and the 3’-SS, respectively (Figure 5.21D). The BP motif UACUAAC was detected around
Mud2- and Msl5-bound sites in intron-containing genes (Figures 5.21A and 5.22) and is generally located
within ~50 nt upstream of the 3’-SS (Figure 5.21E). When we averaged occupancy profiles after aligning
introns at the BP, Msl5 displayed a peak on the BP (Figure 5.21F), consistent with binding of yeast Msl5 to
the BP in vivo. Mud2 and Ist3 peaked 15 nt and 27 nt downstream of the BP, respectively (Figure 5.21F).
Thus we could resolve binding of the U2AF65 homolog Mud2 to a pyrimidine/U-rich region that was
defined in vitro in the human system (Mackereth et al., 2011). These results agree with in vitro-derived
functions of the Msl5-Mud2 complex in BP recognition (Berglund et al., 1997), and in bridging between
the BP and U1 snRNP at the 5’-SS (Abovich and Rosbash, 1997). Msl5 and Mud2 cross-linked also
to intron-less RNAs (Figures 5.15 and 5.19), consistent with scanning of RNAs for U-rich regions by
the U2AF65-BBP complex. Cross-links of U1 snRNP subunits peaked ~17 nt downstream of the 5’-
SS (Figure 5.21D). Motif searches around cross-linking peaks (±25 nt) detected the consensus 5’-SS
sequence GUAUGU in Luc7, Mud1, Nam8, and Snp1 data (Figures 5.21A and 5.22). As expected,
cross-link sites of U1 snRNP subunits were not significantly enriched around the BP (Figure 5.23). The
U2 subunit Ist3 cross-linked mainly ~10 nt upstream of the 3’-SS (Figure 5.21D).
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Figure 5.21: Conserved recognition of pre-mRNA introns in vivo. A. Normalized and smoothed occupancy
profiles of U1 subunits Nam8, Mud2 (human U2AF65) and U2 subunit Ist3 around introns of up to 600 nt
length. Introns were sorted by length and aligned at their 5’-splice site (5’-SS). B. Transcript-averaged
occupancy profiles of all factors around introns between 150 and 600 nt length. C. Splicing factors
show high affinity for unspliced RNAs. Splicing indices (Methods) indicating the degree of preference
for spliced versus unspliced RNAs for all factors. D. Intron-averaged factor occupany profiles show
binding of U1 snRNP near the 5’-splice site and binding of the U2 snRNP and the commitment complex
(BBP/U2AF65) over the entire intron with a peak at the 3’-splice site (3’-SS). E. The branch point (BP)
lies within 50 nt upstream of the 3’-SS. Distance distribution of the branch point (BP) motif from the
3’-SS. F. Yeast Msl5 (human BBP) binds the BP in vivo, whereas Mud2 (U2AF65) and U2 snRNP (Ist3)
bind downstream of the BP. Transcript-averaged occupancy profiles of Msl5, Mud2, and Ist3, centered
at the BP (top), compared to the poly(U) distribution over the same region (bottom).
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Figure 5.22: Occupancy of splicing factors around introns. Occupancy profiles of the U1 snRNP splicing factors
Mud1, Luc7, and Snp1, and the BBP/Msl5 derived from PAR-CLIP experiments for all intronsEach
line represents an intron, and introns are sorted by length and aligned at their 5’-SS. Motifs found by
XXmotif to be enriched ±20 nt around the cross-linking sites are shown next to the factors around
which they are enriched.
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Figure 5.23: Occupancy of splicing factors around the branch point (BP). Average occupancy profiles for the
U1 snRNP Luc7, Mud1, Nam8 and Snp1, and the U2 snRNP Ist3 around the BP.
These results agree with the in vitro-derived binding of U1 and U2 snRNPs near the 5’-SS and the
3’-SS, respectively (Will and Lhrmann, 2011). The splice site RNA motifs were apparently responsible
for recruitment of U1 and U2 snRNPs, because their subunits generally did not cross-link to intron-less
RNAs (compare Figure 5.15 and Supplementary Figure S1). To investigate the order of factor binding to
introns, we calculated a ’splicing index’ (Figure 5.21C, Supplementary Figure S2, and Methods) (Schnei-
der et al., 2012). All splicing factors obtained negative splicing indices, demonstrating preferential binding
to unspliced RNA. The strongest preference for unspliced over spliced RNA was obtained for Mud2, the
weakest for Ist3. Thus our in vivo data support the two-state model of intron recognition derived from in
vitro studies (Figure 5.20).
5.3.3 Unified recognition of pre-mRNA polyadenylation sites
In human cells, recognition of the pA site involves several RNA sequence elements that are bound by the
cleavage and polyadenylation specificity factor (CPSF) complex (Mandel et al., 2008; Chan et al., 2011;
Proudfoot, 2011). The CPSF subunit CPSF-160 recognizes the pA signal (PAS) sequence AAUAAA up-
stream of the pA site. Subunits CPSF-100 and CPSF-30 bind neighboring U-rich sequences, and subunit
CPSF-73 cleaves the RNA (Mandel et al., 2008; Chan et al., 2011). Homologous subunits are found in the
yeast CPSF counterpart CPF, which also contains additional proteins, such as Mpe1 (Vo et al., 2001).
After extensive trials we could map CPF subunits Cft2/Ydh1 (CPSF-100), Yth1 (CPSF-30), and Mpe1
onto transient pre-mRNA (Figure 5.24A). Cft2 cross-linked to regions flanking the pA site, consistent with
binding near the cleavage site detected in vitro (Dichtl and Keller, 2001). Yth1 showed a peak ~17 nt
upstream of the pA site, consistent with in vitro results (Barabino et al., 2000), and with localization of
its human counterpart CPSF-30 in vivo (Martin et al., 2012). Mpe1 gave rise to a peak ~6 nt upstream
the pA site, explaining why it is an essential factor required for 3’-processing (Vo et al., 2001). Although
Cft1/Yhh1 (CPSF-160) and Ysh1 (CPSF-73) did not show PAR-CLIP signals, these data locate the yeast
CPSF counterpart CPF at the pA site in vivo and define many of its subunit-RNA interactions. Human
CPSF is assisted by the CstF complex, which binds to pre-mRNA downstream of CPSF (Mandel et al.,
2008; Chan et al., 2011). However, the yeast CstF counterpart CFIA is believed to bind upstream of the
CPSF counterpart CPF (Mandel et al., 2008; Chan et al., 2011), and this model is based on in vitro evi-
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dence that the CFIA subunit Rna15 binds upstream of the pA site (Gross and Moore, 2001). In contrast,
we observed very strong cross-linking of the CFIA subunit Rna15 downstream of the pA site in vivo, with
a peak at ~16 nt (Figure 5.24A).
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Figure 5.24: Binding preferences of Rna15 and CPF subunits Cft2, Mpe1, and Yth1). A. Averaged occupancy
profiles of Rna15 and CPF subunits, aligned at the pA site show that, in vivo, CPF binds at the pA site
while CFIA binds downstream. B. RNA motifs enriched in a window of ±25 nt around the cross-linked
sites with fraction of occurrence and XXmotif E-value.
These results agree with an alternative in vitro study (Dichtl and Keller, 2001), and with binding of the
human Rna15 homologue CstF64 downstream of the pA site in vivo (Martin et al., 2012). Thus CFIA is
located downstream, rather than upstream, of the pA site and CPF, consistent with the position of the
human CstF complex downstream of the pA site and downstream of the CPF counterpart CPSF. These
results lead to a unified model for pA site recognition by the two conserved 3’-processing complexes
bound to pre-mRNA (Figure 5.25C).
5.3.4 Definition and decoration of mRNA 3’-ends
To investigate how the pA site is defined in the pre-mRNA sequence, we searched for sequence motifs
around cross-linking peaks. Peaks for Yth1 and Mpe1 often contained the motif UAUAUA and AUAAUU,
respectively, whereas Rna15 often bound at the motif UUUUCUU (Figure 5.24B). Cft2, Mpe1, and Yth1
preferred RNA sites containing U/A-rich tetramer sequences, whereas Rna15 bound regions that were
enriched with the A-less tetrameric motifs UUUU and UCUC (Figure 5.25A). Although these motifs are
often absent from pA regions, a systematic analysis revealed a characteristic, conserved signature of
RNA dinucleotides around pA sites (Figure 5.25B). The pA sites are strongly enriched with dinucleotides
UC (at position +1 downstream of the cleavage site), CA/AA (+2), AA/UC (+3), CA/AA (+4), and AA (+5).
Regions with strong UU bias flank pA sites on both sides (-15 to -2 and +6 to at least +25). Further
upstream, a region with marked AA bias (-25 to -15), transitions into a region with enrichment for AU/UA
77
5 Results and Discussion
dinucleotides (-90 to -25). The distinct A/U signature at the pA site apparently directs binding of CPF
subunits upstream and around pA sites and binding of Rna15 downstream of pA sites, because these
factors exhibit corresponding sequence preferences (Figure 5.25A). In some yeast mRNAs, the A-rich
upstream region contains a positioning element that may bind Cft1 and may correspond to the human
polyadenylation signal (Guo and Sherman, 1996), and a UA-rich efficiency element (Guo et al., 1995)
that may bind CFIB/Hrp1 (Kessler et al., 1997). These elements are however dispensable for RNA cleav-
age (Dichtl and Keller, 2001), indicating that the A/U signature, rather than specific sequence elements,
underlies pA site recognition. A similar A/U dinucleotide signature can explain the previously described
bias for A and U nucleotides around human pA sites (Martin et al., 2012) and matches the conserved
arrangement of 3’-processing factors.
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Figure 5.25: Unified model for polyadenylation (pA) site recognition in vivo. A. 3’-processing factors have
distinct tetramer-binding preferences. Log-odd scores for enrichments of selected tetramers (y-axis)
for bins of binding sites ranging from 100 % occupancy to 1 % occupancy (x-axis). B. ’A/U signature’:
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Additional data showed that the region upstream of pA sites bind Pab1 and Pub1 (Figure 5.26). Both
factors gave rise to cross-linking near the 3’-end of mRNAs (Figure 5.26A, C). Pab1 bound upstream of
the pA site to the sequence motif UAUAUA (Figure 5.26A-C) as described (Riordan et al., 2011; Tuck
and Tollervey, 2013). Pub1 occupied both UA-rich regions in the 3’-UTR as described (Vasudevan and
Peltz, 2001; Duttagupta et al., 2005) but also poly(U) tracts (Figure 5.26B), and also bound upstream of
the open reading frame (ORF) in the 5’-UTR (Figure 5.27) as described (Cui et al., 1995; Ruiz-Echevarra
et al., 1998; Ruiz-Echevarra and Peltz, 2000). Pub1 and Pab1 were generally depleted from the trans-
lated ORF (Figures 5.26 and 5.27), consistent with a mainly cytoplasmic location of these factors.
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Figure 5.26: Pab1 and Pub1 bind UA-and U-rich sequences at mRNA 3’-ends. A. Occupancy profiles of the
”poly(A)-binding protein” Pab1 and the ”poly(U)-binding protein” Pub1 derived from PAR-CLIP data in
sense direction for all ORF-Ts with motifs that were found enriched around binding sites (± 25 bp).
B. Pab1 and Pub1 bind to U/A-rich sequences. Log2 enrichment of selected 4-mer motifs around
Pab1 (left) and Pub1 (right) binding sites compared to unbound sequence regions, analyzed within 18
equal-sized bins of occupancy quantiles between 100 % and 1 % site occupancy (x-axis). C. Averaged
occupancy profiles of Pab1, Pub1 and Yth1 derived from PAR-CLIP data in sense direction for all
ORF-Ts, centered at the pA site of all ORF-Ts.
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Taken together, these data may be explained as follows. The two major 3’-processing complexes CPF
and CFIA preferentially locate their target regions on the pre-mRNA around the pA site via a distinct A/U
dinucleotide signature, causing RNA cleavage, polyadenylation, and release of 3’-processing factors,
which enables complete decoration of the mRNA 3’-end with Pab1 and Pub1.
5.3.5 Transcription-coupled mRNP export
In our current view, mRNA export begins with the recruitment of the THO/TREX complex during Pol II
elongation (Strsser et al., 2002; Luna et al., 2012). Mature mRNA is then exported from the nucleus
by the heterodimeric export factor Mex67-Mtr2 (Segref et al., 1997; Grter et al., 1998). Mex67 uses
mRNA adaptor proteins such as Nab2, Npl3, and Yra1 (Iglesias et al., 2010; Stewart, 2010; Hackmann
et al., 2011; Rodrguez-Navarro and Hurt, 2011). PAR-CLIP analysis revealed similar distributions of the
THO subunits Tho2 and Hpr1 over mRNAs (Figure 5.28A and Supplementary Figure S3) and no mRNA
preferences, indicating that the THO complex is a general factor associated with Pol II transcripts.
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bound ORF-Ts (100–90 %). B. ORF-T-averaged occupancy profiles for Mex67.
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Tho2 gave stronger signals, consistent with its role in THO complex recruitment (Chvez et al., 2000;
Gewartowski et al., 2012). Mex67 bound RNA in vivo (Figure 5.28B), explaining how it remains bound
to mRNA after release of adaptor proteins. Mex67 did not show any preference for RNA motifs, consis-
tent with its function as a general export factor, and consistent with data obtained by CRAC (Tuck and
Tollervey, 2013). The export adaptors Nab2, Npl3, and Yra1 showed different cross-linking patterns, in-
dicating specific, non-redundant functions (Figure 5.29). The number of mRNAs bound by two or three
export adaptors simultaneously was limited (Figure 5.29), showing that these factors exhibit mRNA pref-
erences, as suggested from purification of mRNAs associated with Yra1 (Hieronymus and Silver, 2003).
Yra1 occupancy decreased before the pA site, whereas Npl3 also showed cross-linking at 3’-ends, con-
sistent with its influence on pA site choice (Bucheli et al., 2007; Deka et al., 2008).
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Figure 5.29: Export adaptors differ in their mRNA-binding preference. Pairwise correlation scatter plots for
occupancies of Yra1, Npl3, and Nab2 on whole ORF-Ts, together with occupancy profiles over all
ORF-Ts.
Whereas Nab2 preferentially bound short mRNAs (Figure 5.29), Yra1 and Sub2 preferred long mRNAs
(Figure 5.30A). Nab2 occupancy was also stronger at the 3’-ends of ORF-Ts as described (Figure 5.28A)
(Tuck and Tollervey, 2013), consistent with its known influence on 3’-processing (Anderson et al., 1993;
Green et al., 2002; Hector et al., 2002; Tuck and Tollervey, 2013). Nab2 sites were enriched for the
motif GUAG (Figure 5.29) as described (Riordan et al., 2011). Thus these data revealed preferences of
components of the mRNA export machinery for RNAs with specific sequences and lengths.
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5.3.6 Global analysis links splicing to 3’-processing
We now subjected all PAR-CLIP data to a global analysis (Figures 5.31 and 5.32). In addition to the splic-
ing index (Figure 5.21C and Supplementary Figure S2), we introduced a ’processing index’ (Methods)
that measures whether factors preferentially bind uncleaved or cleaved mRNA (Supplementary Figure
S4). A plot of splicing versus processing indices (Figure 5.31A) indicates how the composition of protein-
RNA complexes is remodeled during mRNP biogenesis (Figure 5.31B).
We further calculated for each pair of factors the Pearson correlation coefficient of the total weighted
occupancies over whole transcripts (Figure 5.32, Methods). This measures the extent to which factors
co-occupy the same transcripts. We further measured the extent to which two factors co-localize in a win-
dow of 25 nt around binding sites (Figure 5.34, Methods). Finally, we computed for each pair of factors
the Pearson correlations between their averaged occupancy profiles, to measure the shape similarity
of binding profiles (Figure 5.33, Methods). The global analysis provided evidence for an ancient link
between splicing and 3’-processing. Splicing factors fell into two groups when sorted by their process-
ing indices (Figures 5.21C and 5.31A). The splicing factors Mud2, Msl5, Snp1, and Luc7 preferentially
bound uncleaved RNA, whereas other splicing factors preferred cleaved RNA (Figure 5.31). Mud2 and
Msl5 profiles were correlated with those of 3’-processing factors Rna15 and Cft2, and Nam8 correlated
with Mpe1, Pab1, and Pub1 (Figure 5.33). Also, Mud2, Msl5, and Nam8 cross-linked near the pA site
(Figure 5.15). Nam8 tended to co-localize with Pub1, whereas Mud2 and Msl5 co-occupied transcripts
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with Hpr1, Hrb1, Nab2, and Npl3, and they co-localized with Rna15 (Figures 5.32 and 5.34). Indeed,
Rna15 preferentially bound unspliced mRNAs (Figures 5.21C and 5.31A), but also showed the lowest
processing index (Figure 5.31A and Supplementary Figure S4), confirming its early binding to pre-mRNA
(Guo and Sherman, 1996; Leeper et al., 2010).
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Figure 5.32: Factor co-occupancy of transcripts. Pairwise Pearson correlation coefficient of the total weighted
occupancies over entire transcripts for all factors.
These results indicate that the machineries for splicing and 3’-processing interact in yeast, as inferred
by genetics (Chanfreau et al., 1996), although it is currently believed that such an interaction is restricted
to mammels (Shi et al., 2009; Martinson, 2011; Proudfoot, 2011). Indeed, 3’-processing may assist in
splicing, like in human cells (Kyburz et al., 2006), but splicing apparently does not influence 3’-processing,
because unspliced and spliced transcripts recruit 3’-processing factors to a similar extent.
5.3.7 Transcript surveillance and fate
The global analysis also elucidated how nuclear export is restricted to mature mRNPs. First, export fac-
tors preferred spliced over unspliced mRNA, and generally did not bind uncleaved RNA (Figure 5.21C
and 5.31A). The highest splicing index was found for Pab1, which binds mature mRNA (Brune et al.,
2005), whereas the lowest splicing index was found for Mud2, which is expected to initiate intron recog-
nition (Will and Lhrmann, 2011). Second, binding profiles for export factors except Nab2 differed from
those of 3’-processing factors (Figure 5.33), reflecting selection of 3’-processed mRNAs by export fac-
tors. Indeed, Mex67 preferred binding to mRNAs lacking the pre-mRNA 3’-tail (Figure 5.31A). Third, the
SR proteins Gbp2 and Hrb1 (Windgassen and Krebber, 2003) overlapped with THO/TREX subunits, and
Hrb1 tended to bind the same transcripts as the Mud2-Msl5 complex (Figure 5.32).
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This is consistent with a role of Gbp2 and Hrb1 in restricting mRNA export to spliced transcripts (Hack-
mann et al., 2014). Gbp2 and Hrb1 showed distinct RNA-binding motifs (Figure 5.30B), and Hrb1 co-
localized with splicing factors Luc7 and Snp1 (Figure 5.34), consistent with a role in splicing (Shen and
Green, 2006; Kress et al., 2008; Will and Lhrmann, 2011). A subset of 3’-processing factors also showed
occupancy profiles that were similar to those of RNA surveillance factors Nrd1 and Nab3 (Figure 5.33).
Rna15 co-localized with Nrd1 and Nab3 on transcripts (Figure 5.34), and cross-linked to aberrant di-
vergent ncRNAs (Supplementary Figure S1). This indicates that some 3’-processing factors are part of
the RNA surveillance machinery that terminates and degrades aberrant RNAs, as predicted by genetics
(Mischo and Proudfoot, 2013). Nrd1 and Nab3 co-localized with Cbc2 (Figure 5.34), and preferentially
bound uncleaved pre-mRNA, in accordance with their role in triggering early termination of transcription.
These observations are consistent with a general nuclear RNA surveillance pathway and suggest that
during RNA synthesis a transient surveillance/3’-processing complex takes a decision whether a tran-
script is subjected to degradation or to polyadenylation and nuclear export.
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Figure 5.34: Co-localization of factor A (rows) within ± 50 nt of strong binding sites of factor B (columns), analyzed
over all ORF-Ts.
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6.1 Conclusion
Here we report high-confidence transcriptome maps for 23 protein factors involved in mRNP biogenesis
in the eukaryotic model system S. cerevisiae. We demonstrate that PAR-CLIP efficiently captures short-
lived unspliced and uncleaved pre-mRNAs. This allowed mapping of splicing factors onto short-lived
introns and of 3’-processing factors within regions downstream of the pA site, which are rapidly removed
and degraded in cells. The distribution of factors over various pre-mRNA species that result from events
during mRNP biogenesis enabled integration of the data into a model for mRNP biogenesis based on
factor occupancy. Yeast is ideally suited for studying pre-mRNA recognition because yeast genes contain
only single introns, thus limiting pre-mRNA complexity.
Most notable insights from our data include the observation of intron recognition by the Mud2-Msl5
(human U2AF65-BBP) and the snRNPs U1 and U2 in vivo, a unified, conserved arrangement of the
two major 3’-processing complexes CPF and CFIA (human CPSF and CstF) at the pA site, and links
of the 3’-processing machinery to RNA splicing and nuclear RNA surveillance. An analysis of the RNA
sequences underlying the cross-linked sites recovered known splicing motifs, revealed a characteristic
A/U dinucleotide signature around the pA site, defined eight specific RNA motifs bound by biogenesis
factors, of which three were new, and showed that most factors exhibited binding preferences for certain
RNA tetrameric motifs. These results support the emerging concept that RNA-binding factors generally
show binding preferences, whereas DNA-binding factors exhibit binding specificities. In particular, 3’-
processing factors detect a strong signature of A/U dinucleotides flanking pA sites, but do not bind an
extended, highly conserved sequence motif that could be detected by standard motif discovery tools. To
achieve high target specificity, multiple interactions of RNA-binding subunits within a functional complex
are often required. In addition, factors often interact with other proteins, such as the Pol II CTD. Synergistic
factor binding is evident within the machineries for splicing and 3’-processing and explains how these
machines locate sites in pre-mRNA despite a scarcity of motifs and poor sequence conservation. It also
explains how mRNA, which is restricted in its sequence due to its coding nature, can evolve to specifically
bind multifactor complexes.
Finally, the data provide new insights into the mRNP life cycle and a resource for further studies. A
global analysis of the data revealed that processes involved in mRNP biogenesis are more tightly coupled
than generally thought. An ancient link between 3’-processing and splicing apparently coordinates both
processes and generates mature mRNPs that are selected for nuclear export. In particular, we observed
direct RNA interactions of splicing factors at the pA site and a differential distribution of splicing factors on
pre-mRNAs before and after RNA 3’-cleavage.
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6.2 Future perspectives
Although this work greatly enhances our knowledge about principles underlying mRNP biogenesis and
(post-)transcriptional regulation, a lot of important questions are still unanswered. For instance, it will be
important to work out how 3’-processing may influence spliceosome dynamics and, more generally, how
the composition of protein-RNA complexes is remodeled during mRNP biogenesis. Here, some of the
ideas and group-internal projects shall be mentioned:
Similar to the ”Nrd1 project” (Schulz et al., 2013), experiments could be performed to further in-
vestigate the Rat1-Rai1 pathway in yeast. For this purpose, the exonucleases Rat1 and Rai1, as
well as various interacting partners (Rtt103, Yth1, etc.), will be chipped and clipped. Additionally,
4tU-Sequencing before and after anchor-away will be performed and correlated with PAR-CLIP
results. To observe effects on transcription, Pol II ChIP-seq profiles are necessary after the anchor-
away experiments, especially in case of Rat1. Previous PAR-CLIP experiments showed binding of
Spt5 downstream of pA site, and might have revealed an unknown connection to Rat1, Rai1 and/
or Rtt103. Consequently, 4tU-Sequencing should also be performed after the yeast DSIF com-
plex (Spt4/5) was anchor-awayed. Spt5 comprises KOW domains that might be responsible for
RNA-binding. Deletions of these Spt5 KOW domains might lead to termination defects that can be
measured.
The PAF complex was first identified in yeast as a Po II-associated factor. PAF comprises five sub-
units (Paf1, Ctr9, Leo1, Rtf1, and Cdc73) and interacts with the TBP, Spt4/5, and FACT (Carrozza
et al., 2003; Zhou et al., 2009; Liu et al., 2009). ChIP experiments revealed the presence of the
PAF complex at both promoter and coding regions of transcriptionally active genes. However, some
of the PAF subunits might bind RNA directly, and CLIP profiles might give new insights into the
PAF-associated network.
The CFIA subcomplex is partly recruited by the Spt5 CTR and partly by RNA (Swanson et al.,
1991; Zhou et al., 2009). It would be interesting to characterize these interactions further. Which
subunit of CFIA physically interacts with the CTR could be discovered by fluorescence anisotropy
measurements of CFIA subunits with a fluorescently labeled CTR peptide. The RNA-binding of
CFIA could be characterized by PAR-CLIP to identify specific RNA sequences or regions that are
bound by this subcomplex. This study could finally be enlarged by including the remaining factors
and subcomplexes of the 3’-end processing machinery.
One important step will be the switch to the other model system like Schizosaccharomyces pombe
or Homo sapiens. For that reason, it will be necessary to adapt both our PAR-CLIP protocol and
computational pipeline to the respective system. In comparison with baker’s yeast, both organisms
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allow a much more intense study of the splicing machinery, especially the process of alternative
splicing. In humans, almost all multi-exonic genes are alternatively spliced, which greatly increases
the biodiversity of proteins that can be encoded by the genome. However, genome-wide analysis
of alternative splicing remains as a challenging task. Now, we might have a powerful tool to study
these complexes and interactions in high resolution.
To address all these questions experimentally, it would be beneficial to automate parts of the ChIP-Seq,
RNA-Seq and PAR-CLIP protocol using an automated pipetting robot. For this purpose, different ap-
proaches should be tested before being implemented into the control and feedback systems of such an
automated station.
Futhermore, following projects will be shared within group-external collaborations:
Our PAR-CLIP data might be useful to develop a new motif-discovery tool, based on k-mer analyses
and variations, or to optimize already published approaches [with Johannes Söding, Max Planck
Institute for Biophysical Chemistry, Göttingen, Germany].
Within this study, we did already clip seven factors of the splicing machinery that are involved in
branch point recognition as well as in the U1 and U2 snRNP formation. To get a better overview
of steps combining the intronome with the splicing machinery, additional factors of the spliceosome
should be clipped and correlated to each other [with Reinhard Lührmann, Max Planck Institute for
Biophysical Chemistry, Göttingen, Germany].
One additional project will be the clipping of ribosomal proteins in yeast to estimate the transcription
rates on miRNA-like RNA targets upon induction of their expression [with Mihaela Zavolan, The
Center of Molecular Life Sciences, University of Basel, Switzerland].
Our PAR-CLIP approach might also be a key method to pursue linkages between metabolism and
gene regulation by networks of RNA-binding enzymes (REMs) [with Matthias Hentze, European
Molecular Biology Laboratory, Heidelberg, Germany].
It was shown that Set1 and H3K4me3 works in a repressive manner (for coding genes) through
promotion of 3’-end antisense transcription of a subset of genes (Margaritis et al., 2012). Here, our
PAR-CLIP protocol might provide new insights into the factor binding affinity [with Frank Holstege,
University Medical Center Utrecht, Utrecht, Netherlands].
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Figure S1: Overview of occupancy profiles of all investigated proteins on ORF-Ts. Smoothed occupancy
profiles around all ORF-Ts were aligned at their TSS, length-scaled such that their pA sites coincided,
and the occupancies averaged over all transcripts. A. Occupancy profiles on sense strand, i.e., on the
proper mRNA. B. Occupany on the transcripts antisense to the annotated mRNA direction. Note the high
occupancy of early termination factors Nab3 and Nrd1, termination factor Rna15, splicing factor Mud2,
and export adaptor Npl3 on antisense transcripts.
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Figure S2: The splicing index is robust with respect to using the coverage of coverage exon-intron or intron-
exon junctions. A. Splicing index calculated using coverage of exon-intron (EI) junctions instead of
arithmetic mean of EI and IE junctions covered. B. Splicing index calculated using coverage of inton-
exon (IE) junctions instead of arithmetic mean of EI and IE junctions covered. C. Splicing index calculated
using arithmetic mean of EI and IE junctions covered.
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Figure S3: Occupancy profiles of TREX complex components Tho2 and Hpr1 around ORF-Ts aligned at their
TSS and sorted by length.
108
Supplementary Figures
−2 −1 0 1 2
cleaved
log2(pre-mRNA/ mRNA)
uncleaved
Rna15
Nrd1
Msl5
Mud2
Luc7
Cbc2
Hrb1
Hpr1
Gbp2
Yra1
Sub2
Nab3
Tho2
Yth1
Snp1
Cft2
Npl3
Mud1
Mex67
Pub1
Ist3
Nam8
Mpe1
Pab1
Nab2
4.13
3.94
3.01
1.94
1.94
1.85
1.70
1.42
1.32
0.83
0.72
0.60
0.53
0.52
0.21
0.07
−0.02
−0.31
−0.46
−0.51
−0.86
−0.87
−1.33
−1.90
−2.13
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